











Title of Document: MODELING GERMLINE BRCA2 
MUTATIONS IN ZEBRAFISH   
  
 Heather R. Shive, DVM, Dipl. ACVP 
  
Directed By: Professor Siba K. Samal, Department of 
Veterinary Medical Science, and 
Dennis D. Hickstein, MD, Experimental 
Transplantation and Immunology Branch, 




Human ovarian cancer is a leading cause of morbidity and mortality in women, but 
the pathophysiology of this disease is not well-defined.  Humans with inherited 
mutations in the breast cancer 2 gene (BRCA2) are at increased risk for developing 
breast and ovarian cancer; however, the relationship between BRCA2 mutation and 
these cancers is not understood.  Studies of Brca2 mutation by gene targeting in mice 
are limited, as homozygous Brca2 mutation typically leads to early embryonic 
lethality.  We established a zebrafish line with a nonsense mutation in brca2 exon 11 
(brca2
Q658X
), a mutation similar in location and type to BRCA2 mutations found in 
humans with hereditary breast and ovarian cancer.  brca2
Q658X
 homozygous zebrafish 
were viable and survived to adulthood; however, juvenile homozygotes failed to 
develop ovaries during sexual differentiation.  Instead, brca2
Q658X
 homozygotes 
developed as infertile males with meiotic arrest in spermatocytes.  Germ cell 
  
migration to the embryonic gonadal ridge was unimpaired in brca2
Q658X
 
homozygotes; thus, failure of ovarian development is not due to defects in early 
establishment of the embryonic gonad.  Homozygous tp53 mutation rescued ovarian 
development in brca2
Q658X
 homozygous zebrafish, reflecting the importance of germ 
cell apoptosis in gonad morphogenesis.  In adulthood, brca2
Q658X 
homozygous 
zebrafish were predisposed to testicular neoplasias.  Additionally, tumorigenesis in 
multiple tissues was significantly accelerated in combination with homozygous tp53 




heterozygous zebrafish.  
These studies reveal a critical role for brca2 in zebrafish ovarian development, 
demonstrate a conserved association for brca2 mutation in reproductive 
tumorigenesis in zebrafish, and indicate that tp53 mutation is an important contributor 
to brca2-associated carcinogenesis.  The brca2
Q658X
-mutant zebrafish line is an 
important resource for studying both gonadogenesis and brca2-associated 
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Chapter 1: Introduction 
Introduction 
Ovarian cancer is a major cause of morbidity and mortality in women.  In the United 
States, it is the 5
th
-leading cause of cancer-related death in women and is 8
th
 among 
the most common female cancers (1).  Moreover, the mortality rate among women 
with ovarian cancer has remained largely unchanged over the last two decades (1, 2), 
despite numerous advances in diagnostic technologies and therapeutic modalities.  
This is largely attributable to the difficulty in detecting ovarian cancer at early stages 
(3-5).  Women who are diagnosed in advanced stages of disease have a substantially 
lower 5-year survival rate than women who are diagnosed before regional or distant 
metastases have occurred (2, 5).  Unfortunately, the majority of women who receive a 
diagnosis of ovarian cancer have already developed metastatic foci by the time that 
disease is detected (5, 6). 
 
An overview of ovarian carcinogenesis 
The pathophysiology of ovarian carcinogenesis is poorly understood.  The majority of 
ovarian tumors are carcinomas, and serous carcinoma is both the most common and 
the most malignant type (7).  Historically, these tumors are thought to arise from the 
ovarian surface epithelium, a thin, mesodermally-derived epithelial layer that covers 
the ovary and is contiguous with the peritoneum (8).   Neoplastic cells are believed to 
arise from clefts or microscopic inclusion cysts that develop in the ovarian surface 




been detected infrequently in the ovarian surface epithelium as incidental findings, 
reliable precursor lesions in the ovarian surface epithelium have been difficult to 
define (9).   
 
Proposed mechanisms for development of ovarian cancer from the ovarian surface 
epithelium have included both physical damage and hormonal signaling.  The 
incessant ovulation hypothesis suggests that ongoing cycles of damage, proliferation, 
and repair to the ovarian surface epithelium during reproductive years may lead to 
neoplastic transformation (3, 4).  Alterations in gonadotropin and steroid hormone 
signaling that occur with aging, pregnancy, and premature ovarian failure are also 
thought to influence ovarian surface epithelial proliferation and transformation (3, 4). 
 
In recent years, several studies have suggested that the fallopian tubular epithelium 
may be an alternative site for the origin of ovarian cancer (5).  In this model, pre-
neoplastic or neoplastic cells originate from tubular epithelia and transfer to the 
ovarian surface (10).  This alternate theory of ovarian cancer pathogenesis has arisen 
from histologic examinations of fallopian tissue from women who have undergone 
salpingo-oophorectomy, either after a diagnosis of ovarian cancer, as a risk-reducing 
procedure in women from high-risk families, or for other therapeutic reasons (9, 11).  
Studies of these tissues have, in some cases, demonstrated microscopic foci of cells 
that range from dysplastic to overtly neoplastic (10).  Serous intraepithelial 
carcinomas (STICs) found in tubular epithelium are often highly proliferative 




similar to ovarian cancer cells (10, 11).  The most common genetic alterations 
detected in STICs are mutations in p53 (10). 
 
Known risk factors for ovarian cancer are few; non-genetic factors associated with 
ovarian cancer susceptibility include age, reproductive history, and hormonal therapy 
(4).   In general, the majority of women who develop ovarian cancer are in the 6
th
 
decade of life (4).    With regard to reproductive history, parity is the strongest 
predictor for ovarian cancer risk.  One or more full-term pregnancies decreases the 
risk for ovarian cancer, while risk is increased in nulliparous women (3, 4).  Some 
studies have indicated that long-term use of oral contraceptives also decreases ovarian 
cancer risk (3, 4), although this correlation has not been substantiated in all study 
populations.  The effects of fertility drugs and post-menopausal hormone replacement 
therapy on ovarian cancer risk remain controversial, but both have been suggested to 
increase risk (3, 4). 
 
Genetics of ovarian cancer 
Multiple genetic aberrations have been associated with ovarian carcinogenesis, 
although many uncertainties remain about the sequence of events leading to 
neoplastic transformation (12).  The majority of ovarian cancer cases are considered 
sporadic, with no known relevant family history to suggest a heritable component to 
the disease (4).  However, some somatically acquired genetic changes have been 
associated with development of sporadic ovarian cancer (7, 13, 14).  Interestingly, 




cancer (Table 1.1).  These observations have led to a classification scheme based on 
histologic type, genetic alterations, and cancer progression (13).  In this scheme, type 
I tumors include low-grade serous carcinoma, mucinous carcinoma, endometrioid 
carcinoma, clear cell carcinoma, and malignant Brenner (transitional) tumor (13, 14).   
Type I tumors, for which defined precursor lesions have been identified, are slow 
growing and often restricted to the ovary at diagnosis (13, 14).  Type II tumors are 
typically high-grade serous or undifferentiated carcinomas (13, 14).  In contrast to 
type I tumors, type II tumors are not associated with any known precursor lesions, are 
highly aggressive, and frequently have metastasized at the time of diagnosis (13, 14).   
 
Hereditary forms of ovarian cancer account for approximately 10% of all cases (15-
17).  Over 90% of hereditary ovarian cancers are associated with pathologic 
mutations in the breast cancer associated genes BRCA1 and BRCA2 (3, 18).  A small 
number of hereditary ovarian cancer cases are associated with mutations in mismatch 
repair genes, most commonly MLH1 and MSH2 (12, 15).  In these instances, ovarian 
cancer predisposition is a component of the hereditary nonpolyposis colorectal cancer 
(HNPCC) syndrome (12, 15).   
 
The type I/II ovarian cancer designation described above has not been formally 
applied to hereditary ovarian cancers, perhaps because these represent a small fraction 
of total ovarian cancer cases.  Most women with hereditary forms of the disease 
develop high-grade serous carcinomas, although other histologic subtypes have been 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































are thought to originate from the tubular or fimbrial epithelium at a frequency equal 
to or above that of sporadic ovarian cancers (20). 
 
In familial cases, ovarian cancer susceptibility occurs in women who are 
heterozygous carriers of pathologic BRCA mutations, and cancer cells frequently have 
loss of heterozygosity (21).  Loss of the wildtype BRCA allele is considered to be an 
important step in carcinogenesis, but the timing of this event in disease pathogenesis 
is unclear (15, 20).  Mutations in p53 are the most common and perhaps most 
significant additional genetic change that occur in BRCA-associated ovarian cancer 
(19, 20).  A recently proposed model for hereditary ovarian cancer originating from 
the tubular epithelium suggests that p53 mutation is an early event in BRCA-
associated ovarian cancer, with loss of heterozygosity leading to overt neoplastic 
transformation (20). 
 
BRCA2 mutation and ovarian cancer risk 
Without a known relevant family history of breast or ovarian cancer, a woman’s 
lifetime risk for developing ovarian cancer is less than 2% (18, 22).  In contrast, 
women carrying deleterious mutations in BRCA2 have a lifetime risk for developing 
ovarian cancer of 20 – 30% (15, 23).  Families with mutations in BRCA2 demonstrate 
an autosomal dominant inheritance pattern for breast and ovarian cancer susceptibility 
(15, 18).  Female carriers of pathologic BRCA2 mutations are at risk for either breast 
or ovarian cancer, which includes the possibility that both cancers may occur in the 




risk for other types of cancer, including a particularly high risk for male breast cancer 
(24, 25). 
 
The majority of known deleterious BRCA2 mutations are frameshift mutations 
resulting in premature termination of the protein coding sequence (3, 15, 26).  A 
lesser number of deleterious nonsense and missense mutations have been described 
(26).  While a small number of defined mutations occur at high frequency in certain 
ethnic groups, most reported BRCA2 mutations arise in single cases or small numbers 
of families (18, 26, 27). 
 
Inherited mutations in BRCA2 are a well-established risk factor for developing 
ovarian cancer (18, 22, 28), but the link between BRCA2 mutation and ovarian cancer 
is not understood.  However, the site of the mutation within the BRCA2 gene may 
give some indication of ovarian cancer risk.  Epidemiologic evidence shows that 
mutations in the “ovarian cancer cluster region” in BRCA2 exon 11 are associated 
with an increased incidence of ovarian cancer relative to breast cancer in affected 
families (16, 29).  These findings suggest that mutations in this portion of the gene 
may increase an individual’s risk for ovarian cancer. 
 
BRCA2 structure and function 
The human BRCA2 gene is 11,387 base pairs with 27 exons, and encodes a 3,418 
residue protein with no significant similarity to any known protein (Fig. 1.1) (30).  






Fig. 1.1 BRCA2 structure and function.  (A) The human BRCA2 gene 
(NC_0000.1310) is 11,387 base pairs with 27 exons, and encodes a 3,418 amino acid 
protein (NP_000050.2).  Red bars represent the BRC repeats required for binding to 
RAD51.  Multiple conserved DNA binding domains are represented by the dark blue 
box.  (B) Following a dsDNA break, BRCA2 binds to RAD51 and facilitates the 
interaction between RAD51 and the DNA strands.  RAD51 mediates error-free repair 
through recombination with a region of homology.  (C) dsDNA breaks induced by 
SPO11 are necessary for meiotic recombination in germ cells.  BRCA2 is required for 
localization of RAD51 and DMC1 to SPO11-induced DNA breaks.  RAD51 and 




homologous recombination (Fig. 1.1) (30-34).  BRCA2 participates in this repair 
process through physical interaction with RAD51, a recombinase that initiates 
chromosomal strand invasion and recombination during DNA break repair (30, 33, 
34).  BRCA2 and RAD51 colocalize at sites of DNA damage (30, 34, 35).  The 
BRCA2-RAD51 interaction occurs via binding of RAD51 to a series of 
approximately 30-40 amino acid motifs, referred to as the BRC repeats, that are 
encoded in exon 11 of the human BRCA2 gene (30, 33, 34). 
  
In addition to its role in mediating homology-directed repair of DNA damage, 
BRCA2 also mediates homologous recombination during meiosis (Fig. 1.1) (34).  In 
meiotically active germ cells, the cellular enzyme SPO11 induces DSB in 
chromosomes in early prophase I (34).  Some DSB are repaired by homologous 
recombination, requiring the activity of BRCA2 (34).  Similar to its role in DNA 
damage repair, BRCA2 is required for the localization of recombinases to DSB sites 
(34, 36).  Meiotic recombination requires two recombinases:  RAD51 and the 
meiosis-specific recombinase DMC1 (34).  The process of homologous 
recombination and crossover between regions of homology within chromatids allows 
for genetic reassortment in gametes (34). 
 
Studies in BRCA2-deficient cell lines have revealed that a variety of chromosomal 
changes can arise in the absence of BRCA2.  These spontaneous chromosomal 
changes include DSB, aneuploidy, tri-radial and quadri-radial chromosomes, and 




increased sensitivity to ionizing radiation, mitomycin C, and other DNA-damaging 
agents (31, 35).  These aberrations are presumably attributable to impaired DSB 
repair; BRCA2 deficient cells exhibit diminished formation of RAD51 nuclear foci 
(30, 31, 35).  In vitro assays for DSB repair demonstrate that repair processes 
mediated by homologous recombination are deficient in these cells (32, 37).  
Deficiencies in DNA repair have been exploited in the treatment of patients with 
BRCA-associated cancers, which are exquisitely sensitive to DNA damaging agents, 
such as cisplatin, and to agents that block alternate DNA repair mechanisms, such as 
poly(ADP-ribose) polymerase (PARP) inhibitors (38, 39).  Interestingly, 
chemotherapeutic resistance in neoplastic cells has been associated with reversion of 
the BRCA mutation (38, 40). 
 
BRCA2 mutation and Fanconi anemia 
 
Surprisingly, BRCA2 mutations are associated with a separate human disease entity, 
Fanconi anemia, that appears unrelated to breast and ovarian cancer susceptibility.  
Fanconi anemia (FA) is a multifaceted syndrome characterized by congenital 
abnormalities, aplastic anemia, leukemia, and solid tumor formation (41).  Mutations 
in a number of genes are associated with this syndrome; these genes are united by 
their roles in the Fanconi anemia DNA damage response and repair pathway (42).  
BRCA2, also known as FANCD1, was identified as a member of the FA complex in 





In contrast to individuals at risk for hereditary breast and ovarian cancer, who are 
heterozygous carriers for BRCA2 mutation, individuals with BRCA2-associated FA 
carry biallelic mutations in BRCA2 (44).  Mutations in BRCA2 that are associated 
with FA include both missense and nonsense mutations (43, 44).  The majority of 
these mutations are considered deleterious; however, no studies have identified 
patients who are homozygous for the same null mutation, suggesting that such a 
situation would prevent viability (44).  Interestingly, many missense mutations in 
BRCA2 that have been identified in FA patients are localized in a tight cluster within 
the carboxy-terminal region (44).   
 
While the spectrum of syndromes that occur in FA patients can be quite diverse, FA 
in individuals with BRCA2 mutations is phenotypically distinct (44).  This is 
particularly evident in BRCA2-associated cancer susceptibility.  The incidence of 
childhood cancers in patients with BRCA2-associated FA is remarkably high in 
comparison to patients with mutations in other FA genes, with a 97% risk for 
developing a malignancy by the age of 5.2 years (44).  These human studies 
demonstrate a clear association between BRCA2 mutations and cancer risk in both 
heterozygotic and homozygotic individuals. 
 
Animal models of ovarian cancer 
Spontaneous epithelial ovarian cancer in animal species is uncommon, with the 
exception of aged hens kept under intensive laying conditions (4, 45).  Various 




Xenograft models employ subcutaneous, intraperitoneal, or sub-bursal injection of 
ovarian cancer cells [reviewed in (46, 47)].  These models are limited by several 
factors:  the necessary use of immunodeficient animals, use of cell lines derived from 
late-stage ovarian cancer, and, in subcutaneous and intra-peritoneal models, failure to 
recapitulate pre-metastatic stages of disease (46, 47). 
 
Development of transgenic mouse models for ovarian cancer has been hindered by 
the lack of promoters specific for the ovarian surface epithelium (OSE) (4, 45-47).  
Connolly et al. describe successful generation of a transgenic model for epithelial 
ovarian cancer by targeting expression of the early region of SV40 to the OSE via the 
promoter for the Müllerian Inhibiting Substance type II Receptor (MISIIR) (48).  In 
this model, ovarian tumors were detectable in some newborn mice.  Transgenic 
female mice developed poorly differentiated ovarian carcinomas as early as 6 weeks 
of age and were infertile, preventing the establishment of a transgenic line (48).  An 
alternative approach for targeting the OSE utilizes the Cre-lox system to locally 
inactivate tumor suppressor genes or activate oncogenes via injection of a 
recombinant adenoviral vector expressing Cre recombinase under the ovarian bursa 
(46).  This system successfully generates epithelial ovarian tumors, but is labor-
intensive, costly, and the results are variable (46). 
 
Animal models of BRCA2 mutation 
Brca2-mutant mouse models have proven equally difficult to generate.  Mouse 




or complete deletion of Brca2 exon 11, are typically characterized by early 
embryonic lethality in homozygotes (Table 1.2).  Homozygous mutant embryos 
exhibit impaired embryonic development, developmental arrest, and decreased 
cellular proliferation (49-53).  Two Brca2-mutant mouse models that were generated 
by targeting exon 11 have produced low numbers of homozygous mutants that 
survive to adulthood (54, 55).  In these studies, homozygous Brca2-mutant mice 
exhibited various developmental defects, gonadal dysgenesis and hypoplasia, 
infertility, and a predisposition for thymic lymphoma (54, 55). 
 
Several Brca2-mutant mouse models with partial or complete loss of exon 27 have 
also been described (52, 56).  In these models, homozygous mutant mice generally 
did not experience high levels of early embryonic lethality, and were fertile (Table 
1.2).  However, homozygous Brca2-mutant mice exhibited a higher incidence and an 
earlier onset of a variety of solid tumors in comparison to control animals (52, 56).  
Irradiation of Brca2-mutant mice with loss of exon 27 increased the incidence of 
some tumor types in both homozygotes and heterozygotes (57). 
 
One mouse model was described in which a Bacterial Artificial Chromosome (BAC) 
containing human BRCA2 was used to rescue embryonic lethality from homozygous 
Brca2 mutation (58).  While viability was restored, the transgene was poorly 
expressed in the gonads, and homozygous Brca2-mutant mice were infertile (58).  
Male homozygotes exhibited incomplete spermatogenesis, meiotic arrest before 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































findings indicated that spermatocytes lacking Brca2 were arrested in early prophase I 
and did not complete meiotic recombination (58).  Female homozygotes exhibited 
progressive oocyte loss and subsequent follicular degeneration; interestingly, some 
oocytes were capable of completing meiosis I (58).  Some oocytes were fertile, but 
frequently exhibited abnormal chromosomal segregation (58). 
 
One rat model for Brca2 mutation has been described with a nonsense mutation in 
Brca2 exon 11 that was derived by Ethylnitrosourea (ENU) mutagenesis (59).  
Homozygous Brca2-mutant rats were fully viable (59), in contrast to what has been 
observed in mouse models (Table 1.2).  This finding suggests that targeted deletions 
of portions of Brca2 are significantly more deleterious than point mutations.  Both 
male and female homozygous Brca2-mutant rats were infertile (59).  Homozygous 
Brca2-mutant male rats exhibited incomplete spermatogenesis and meiotic arrest 
(59), similar to findings in Brca2-mutant mice described by Sharan et al. (58).  
Ovaries from homozygous Brca2-mutant female rats were not described (59).  Brca2 
homozygotes experienced decreased survival and increased tumor incidence in 
comparison to Brca2 heterozygous and wildtype cohorts (59).  Brca2 homozygotes 
developed a variety of tumor types, including ovarian thecomas and granulosa cell 
tumors in female Brca2 homozygotes (59). 
 
The introduction of p53 mutation in Brca2-mutant mouse models has produced 
variable results.  Loss of p53 in homozygous Brca2-mutant mice with the mutation 




survival (51).  In homozygous Brca2-mutant mice with the mutation targeted to exon 
27, p53 mutation increased tumorigenesis and reduced survival (57).   
 
Some conditional mouse models with tissue-specific deletion of Brca2 have been 
developed that target Brca2 mutation to mammary epithelium, skin, salivary gland, 
thymocytes, and peripheral T-cells [(60) and reviewed in (61, 62)].  In some models 
that targeted mammary epithelium, an increase in mammary tumorigenesis was 
reported (60-62).  Concurrent p53 mutation enhanced mammary tumorigenesis in 
both homozygous and heterozygous Brca2-mutant mice, including increased tumor 
incidence and reduced latency of tumor formation (61, 62).  Targeting Brca2 
mutation to the thymus resulted in thymic lymphoma in 25% of homozygotes (60). 
 
These studies of Brca2 mutation in murine models indicate that Brca2 is important 
for embryonic survival.  Viable Brca2-mutant models have demonstrated that 
homozygous Brca2 mutation is associated with tumorigenesis in multiple tissues, and 
tumorigenesis can be enhanced by p53 mutation (52, 54-57).  Homozygous Brca2 
mutation is additionally associated with defects in spermatogenesis and meiotic arrest 
(58, 59).  Some of the variations in phenotypes among different Brca2-mutant rodent 
models are likely to reflect the effects of strain background and the methods used to 
introduce mutations in Brca2 (62).  No significant phenotype has been observed thus 





Zebrafish as a cancer model 
 
The zebrafish (Danio rerio) emerged as a vertebrate model system for research in the 
1930’s, with initial work focusing on embryological development (63). This model 
offers certain advantages over traditional vertebrate models, including rapid 
generation time, high stocking density in small areas, external embryonic 
development, transparent embryos, high fecundity, and lower maintenance costs (64).  
Furthermore, numerous methods for genetic manipulation and generation of zebrafish 
lines with specific genetic alterations are feasible (63, 64).   
 
Chemical mutagenesis through exposure to Ethylnitrosourea (ENU) is one of the 
most widely utilized techniques for genetic manipulation in the zebrafish model (63-
67).  ENU mutagenesis strategies permit the establishment of libraries of mutation-
carrying zebrafish; these libraries may be screened for mutations in specific genes of 
interest (Fig. 1.2) (66, 68). To establish a mutant library, wild-type male zebrafish are 
exposed to ENU and subsequently bred to wild-type females, and the F1 male 
progeny are sacrificed for collection of DNA and sperm samples (66, 68).  Banked 
DNA may be screened efficiently by large-scale resequencing and/or TILLING 
(Targeting Induced Local Lesions IN genomes) strategies to identify mutations in a 
particular gene (68).  A mutation of interest found in a particular DNA sample may be 
recovered by using the corresponding sperm sample for in vitro fertilization (68).  
Resurrection and establishment of the mutation in a zebrafish line are achieved by 






Fig. 1.2 Generation and screening of an ENU-mutagenized zebrafish library.  
Wildtype adult male zebrafish are exposed to ENU and subsequently crossed to 
wildtype female zebrafish.  The F1 males from this cross are sacrificed for sperm 
cryopreservation and DNA extraction.  DNA samples from the ENU-mutagenized 
library can be screened for mutations in genes of interest by PCR and sequencing.  If 
a mutation of interest is found, the matching cryopreserved sperm sample is used for 




Screening of ENU-mutagenized libraries has been used to recover mutations in the 
zebrafish recombination-activating gene 1 (rag1), tp53, and adenomatous polyposis 
coli gene (apc) (69-71).  Both the tp53-mutant and apc-mutant zebrafish lines 
exhibited increased cancer susceptibility, demonstrating conservation of function of 




The zebrafish brca2 gene was recently described and mapped to chromosome 15 
(72).  The zebrafish brca2 gene is 16,391 base pairs with 27 exons, and encodes a 
2,874 amino acid protein (Fig. 1.3).  Zebrafish brca2 contains a large exon 11, similar 
to other species.  A genomic analysis of zebrafish brca2 revealed highly conserved 
domains and conservation of synteny for neighboring genes (72).  Conserved domains 
include the BRC repeats in exon 11, which are required for BRCA2-RAD51 binding, 
and multiple DNA binding domains in the C-terminal portion of the protein (Fig. 1.3 
and Appendix I).    
 
Zebrafish gonads are comparable to mammalian gonads 
The basic morphology, structural organization and intercellular relationships of 
zebrafish ovaries and testes have been described.  The adult zebrafish ovary is a 
bilobed structure with numerous connective tissue folds (ovigerous lamellae) that 
contain developing oocytes and follicles (73). Somatic cell populations in the 






Fig. 1.3 Structure of zebrafish brca2.  (A)The zebrafish brca2 gene (NCBI 
NC_007126.4) is 16,391 base pairs with 27 exons.  (B) Zebrafish brca2 encodes a 
2,874 amino acid protein (NCBI NP_001103864.2).  Conserved domains include the 
Rad51-binding BRC repeats (red bars) and the DNA binding domain (dark blue box), 
which consists of several individual motifs, including a helix (residues 2021-2212), 
tower (residues 2376-2417), and three “OB” domains (residues 2596-2737, 2214-





ovaries), thecal cells, the ovarian surface epithelium, and components of the 
fibrovascular stroma (73).  Unlike mammalian follicles, in which multiple layers of 
granulosa cells surrounding a developing oocyte, zebrafish oocytes are surrounded by 
a single layer of follicle cells (73).  The ovarian surface epithelium in zebrafish is a 
thin, flattened layer of epithelial cells that covers underlying developing follicles (73). 
The earliest developmental stage is the oogonium, which resides in nests and is 
distinguished from somatic cells by its relatively large size and nuclear:cytoplasmic  
 ratio (73).  Subsequent development phases of oocytes are categorized as stages I 
through V, based on criteria established by light and electron microscopy (Table 1.3) 
(73).  After oocytes are recruited to develop, they arrest in diplotene I until they 
complete maturation (73).  Oocytes are surrounded by somatic cells at the completion 
of Stage I, which forms the definitive follicle (73).   
 
Multiple morphologic changes occur in and around developing oocytes as they 
continue to mature.  These include development of a vitelline envelope in the 
cytoplasm (Stage II); proliferation of follicular and thecal cells around oocytes (Stage 
II); and onset of vitellogenesis (Stage III) (73).  Vitellogenesis refers to the 
accumulation of yolk in the cytoplasm; yolk is derived from vitellogenin, a precursor 
produced by the liver and transported by endocytosis into developing oocytes (73).  
Oocytes complete maturation when they are ovulated into the oviduct (73). 
 
Like mammalian species, oocyte maturation and follicle development in the zebrafish 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































hormone) and LH (luteinizing hormone) (74).  There are also complex intercellular 
signaling pathways within the ovarian microenvironment that further regulate 
oogenesis, similar to what occurs in mammalian ovaries (74).  This paracrine 
signaling network involves growth hormones (e.g. activin and follistatin), and steroid 
hormones (e.g. maturation-inducing steroids and estradiol), which control the onset 
and progression of oocyte maturation (74).   
 
The mature zebrafish testis shares many features of mammalian testes (Table 1.4).  
The testis is organized into the tubular compartment, containing developing germ 
cells and Sertoli cells, and the intertubular/interstitial compartment, containing 
Leydig cells and vascular, structural, and neural elements (75, 76).  Fish species 
undergo cystic spermatogenesis, which indicates that cytoplasmic extensions from 
Sertoli cells encircle and support a single group of clonally derived, synchronously 
developing germ cells (75, 76).  This structural unit is referred to as a spermatocyst 
(75, 76).  Within a testicular tubule, there are multiple differently sized spermatocysts 
containing germ cells at different stages of development (75, 76).  The process of 
spermatogenesis is conserved among vertebrates and includes three phases:  1) the 
mitotic or spermatogonial phase; 2) the meiotic phase; and 3) the spermiogenic phase 
(75, 76).  Each phase incorporates specific populations of germ cells, namely 
spermatogonia (mitotic phase), primary and secondary spermatocytes (meiotic phase), 
and spermatids and spermatozoa (spermiogenic phase) (Table 1.4) (75, 76).  The first 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































alignments and meiotic recombination; thus, the majority of spermatocytes observed 
at any given time in testicular tubules are primary spermatocytes (75).   
 
Similar to mammals, the pituitary gonadotropins FSH and LH are the most important 
regulators of testicular physiology; however, the specific roles for these hormones in 
steroidogenesis are not well defined (75).  Several growth factors in fish species have 
been identified that are produced by Sertoli cells to regulate germ cell proliferation 
(75).  In addition, a number of steroid hormones, including androgens, progestins, and 
estrogen, have been shown to regulate spermatogenesis in a manner similar to 
mammalian testes (75).   
 
Juvenile gonad development in zebrafish 
Although structural and functional organization of the gonads is conserved in 
zebrafish, gonad development in zebrafish occurs differently than in mammalian 
species.  Immature zebrafish experience a period of so-called “juvenile 
hermaphroditism” during development, which refers to development of a “juvenile 
ovary” in immature zebrafish of both sexes (Fig. 1.4) (77).  The timing of this phase 
is variable within a population of zebrafish (78, 79).  Generally, zebrafish undergo 
juvenile ovary development between 3 to 4 weeks of age (78, 79), although juvenile 
ovary development has been reported to begin as early as 12 days post fertilization 
(dpf) (77).  This variability among timing of gonad development may be related to 






Fig. 1.4 Juvenile gonad development in zebrafish.  During the juvenile period, 
wildtype zebrafish develop a juvenile ovary characterized by the presence of 
perinucleolar oocytes (arrowheads).  Female sexual differentiation is characterized by 
continued maturation of oocytes and ovarian development.  Male sexual 
differentiation requires degeneration and apoptosis of perinucleolar oocytes and 
spermatocyte proliferation before testicular development occurs.  Scale bars, 50 µm 





During this period, all wildtype zebrafish develop immature oocytes in the juvenile 
gonads (77).  Histologically identifiable cell populations in the juvenile ovary include 
oogonia, early meiotic stage primary oocytes, and perinucleolar oocytes (78).  
Perinucleolar oocytes, which are distinguished by large nuclei, basophilic cytoplasm, 
and peripheralized nucleoli, are used as the defining feature of the juvenile ovary in 
studies of zebrafish gonad development (78, 80).  While all zebrafish develop 
perinucleolar oocytes, the extent of oocyte development and duration of oocyte 
retention is highly variable within populations of putative male zebrafish (79).  The 
reasons for this variation among male zebrafish are not known (79). 
 
As zebrafish continue to mature, female zebrafish exhibit retention, proliferation, and 
continued differentiation of oocytes (78, 79).  Small numbers of apoptotic germ cells 
can be found in presumptive female gonads during this period (80).  In contrast, 
gonads from presumptive male zebrafish exhibit degeneration and apoptosis of 
numerous germ cells (77, 78, 80).  Subsequently, presumptive male gonads develop 
small groups of germ cells in cyst-like clusters surrounded by somatic cells, which 
represent nascent spermatogonial cysts (78).  Male and female zebrafish reach sexual 
maturity at approximately three months of age (81). 
 
Interestingly, the germ cell compartment plays a relatively greater role in gonad 
differentiation and sex determination in zebrafish than in mammals.  In zebrafish, as 
in other animal species, primordial germ cells (PGCs) are specified early in 




PGC migration is blocked, resulting in apoptotic loss of PGCs in early 
embryogenesis, zebrafish will invariably develop as males (83, 84).  The gonadal 
somatic tissues in these PGC-ablated zebrafish develop into tubular structures 
resembling testes, and express the male-specific genes amh and sox9a (85).  
Similarly, homozygous mutations in genes that are critical for germ cell survival and 
development, such as nanos1, ziwi, and zili, result in development of all-male 
zebrafish populations (86-88).  These studies indicate that primordial germ cells play 
a fundamental role in gonadogenesis and sex determination in zebrafish. 
 
Zebrafish sex determination:  similarities and differences to mammalian species 
Zebrafish, like many animal species, are sexually dimorphic as adults.  Although 
some fish species can experience sex reversal after reaching sexual maturity, 
zebrafish do not undergo sex reversal once final gonadal development has occurred 
(89).  The processes that direct sexual differentiation and gonadogenesis in zebrafish 
are not fully understood (90, 91).   
 
An important difference between zebrafish and mammalian species is that zebrafish 
do not have defined sex chromosomes (92, 93).  Whereas male and female animals 
possess X and Y chromosomes that dictate sexual differentiation and gonad 
development (94), sex determination in zebrafish appears to involve multiple 
autosomal genes (95-97).  In addition, development of male or female populations in 
many fish species can be affected by environmental factors, such as water 




of defined sex chromosomes is not unique to zebrafish; however, there are examples 
of fish species which do possess an X and Y sex-determining system, such as the 
Japanese medaka (99).   
 
Although zebrafish sex determination is not directed by defined X and Y 
chromosomes, the downstream signaling pathways that regulate testicular or ovarian 
differentiation appear to be conserved (75, 91).  In male mammals, testicular 
differentiation is directed by the Sry gene, which induces SOX9 expression in Sertoli 
cell precursors (100).  SOX9 activates expression of the anti-Müllerian hormone gene 
(AMH), inducing regression of the Müllerian ducts (101, 102).  AMH also blocks 
expression of the aromatase gene Cyp19a1, thus preventing conversion of androgens 
to estrogens (103).  In the absence of Sry in female mammals, SOX9 levels do not 
increase; thus, aromatase mediates androgen-to-estrogen conversion, the Müllerian 
ducts persist, and the embryonic gonad undergoes feminization (104-106).  
 
In zebrafish, an Sry-like gene has not been defined.  However, key downstream genes 
that are critical for mammalian sex determination are also found in zebrafish.  There 
are two sox9 genes in zebrafish (sox9a and sox9b) (107), which are the result of a 
genomic duplication event during teleost evolution (108).  Similarly, there are two 
cyp19a1 genes in zebrafish (cyp19a1a and cyp19a1b) (109).  In adult zebrafish, the 
sox9 genes are expressed in multiple tissues; interestingly, sox9a is expressed in 
testes, while sox9b is expressed in ovaries (107).  cyp19a1a expression is limited to 




testes, and in follicular cells in adult ovaries (110), similar to patterns of Amh 
expression in mammals (111).  These expression patterns in adult zebrafish gonads 
imply that sox9, cyp19a1, and amh play conserved roles in sex determination. 
 
Analyses of sox9a, amh, and cyp19a1a expression in developing zebrafish gonads 
provide further evidence that the roles for these genes in male versus female gonad 
development are conserved.  Undifferentiated gonads exhibit expression of all three 
genes (110).  Early testicular development correlates to increased expression of sox9a 
and amh and loss of cyp19a1a expression (110).  In contrast, early ovarian 
development is characterized by expression of only cyp19a1a (110).  Several 
microarray analyses comparing gene expression in both adult and juvenile gonads 
have supported these data, and have also suggested that expression patterns 
temporally coincide to stages of juvenile gonad development (95, 96, 112). 
 
These studies indicate that conserved signaling pathways for sex differentiation exist 
in zebrafish, which are comparable to the signaling pathways that direct sex 
determination that occur in mammals.  However, no single gene that is responsible 
for directing sex determination and gonad differentiation has yet been identified in 
zebrafish. 
 
In summary, previous studies of gonadal development, structural organization, and 
intercellular signaling in zebrafish indicate that many of these elements are conserved 




morphogenesis and sex determination are distinctly different between zebrafish and 
mammalian species.  These similarities and differences are important factors to 
consider when using the zebrafish as a comparative model for gonadal 
pathophysiology. 
 
Thesis goals and outline 
BRCA2 is critical for error-free repair of double-strand DNA breaks in many cell 
types, and mutations in BRCA2 impact both DNA damage repair in somatic cells as 
well as meiotic progression in germ cells.  While the loss of homologous 
recombination repair processes in BRCA2-deficient cells is thought to lead to 
neoplastic transformation, much remains unclear about the process of BRCA2-
associated carcinogenesis.  Studies of Brca2 mutation in murine models have 
provided limited insight due to early embryonic lethality, and studies in viable models 
have not explained the link between BRCA2 mutation and ovarian cancer.  Zebrafish 
represent a novel alternate model for studying brca2 mutation that may provide new 
insights into these topics. 
 
The proposed studies are designed to generate a zebrafish model for brca2 mutation 
to investigate the effects of brca2 mutation in vivo, from embryonic development to 
adulthood.  This model will incorporate three known risk factors for human ovarian 
cancer:  BRCA2 mutation, age, and reproductive history.  These studies will include 
investigation of brca2-associated tumorigenesis and contribution of other genetic 




zebrafish with brca2 mutations comparable to mutations in humans with hereditary 
ovarian cancer will provide a model system in which to assess recognized risk factors 
for ovarian cancer and identify collaborating factors in ovarian carcinogenesis.   The 
three specific aims designed to test this central hypothesis are: 
 To characterize the zebrafish ovarian surface epithelium in immature and 
adult wildtype and mutant female zebrafish with different reproductive 
histories.    
 To assess the expression and role of brca2 during zebrafish development.  
 To determine the effects of specific brca2 mutations on ovarian tumorigenesis 
in zebrafish.  
Establishing a model for BRCA2-associated cancer in a genetically tractable model 
such as the zebrafish provides a unique opportunity to investigate and identify 
collaborative factors in carcinogenesis, and represents a potential in vivo system for 
assessing novel therapeutic interventions. 
 
Chapter 2 will focus on evaluating the zebrafish as a model for BRCA2-associated 
cancer, particularly ovarian cancer.  In these studies, the expression patterns of brca2 
during development and in adulthood are examined in order to determine the potential 
results of brca2 mutation.  Histologic characteristics of the zebrafish ovary and testis 
are evaluated to establish a basis from which to assess zebrafish gonadal 
pathophysiology.  Additionally, the potential for using reproductive history as a risk 





In Chapter 3, a brca2-mutant zebrafish line is established with a mutation in exon 11, 
a mutation similar in location and type to humans with hereditary ovarian cancer (17).  
The effects of brca2 mutation on zebrafish embryogenesis and gonad development 
are investigated with this model.  These studies will show that brca2 is not required 
for embryogenesis in zebrafish, but is essential for spermatogenesis in adult males.  In 
addition, these investigations demonstrate that brca2 is required for ovarian 
development in zebrafish. 
 
Chapter 4 explores the mechanisms for failure of ovarian development in brca2-
mutant zebrafish and the effects of brca2 mutation on tumorigenesis.  In these 
studies, germ cell apoptosis during gonadal development is determined to be critical 
in preventing ovarian development in brca2-mutant zebrafish.  In adults, brca2 
mutation is associated with tumor development in reproductive tissues.  Concomitant 
mutations in brca2 and tp53 result in accelerated tumorigenesis in multiple tissues, 
and are associated with primary tumor development in the ovary.  These studies 
indicate that the role for BRCA2 mutation in reproductive tumorigenesis, and the 







Chapter 2:  The zebrafish as model for brca2-associated ovarian cancer 
Introduction 
Despite numerous diagnostic and therapeutic advances in oncologic research and 
clinical practice, human ovarian cancer remains a leading cause of morbidity and 
mortality in women (1).  Significantly, the long-term survival rate for women 
diagnosed with ovarian cancer has remained largely unchanged over the last several 
decades (2).  This lack of progress is attributable at least in part to lack of knowledge 
about ovarian cancer pathogenesis, particularly the early stages of disease (20).   
 
There are few known risk factors for ovarian cancer, and BRCA2 is among a small 
number of genes associated with hereditary ovarian cancer (12, 15, 18, 28). Thus far, 
insights gained from traditional murine models into BRCA2-associated carcinogenesis 
are limited (61, 62).  Therefore, new animal models are needed for the study of 
ovarian pathophysiology and BRCA2 mutation in vivo. 
 
We used the zebrafish as a model for investigating two known risk factors for ovarian 
cancer:  BRCA2 mutation and reproductive history.  In these studies, we assessed the 
suitability of zebrafish as a comparative model for studying adult gonads, particularly 
the ovary.  We examined the expression of brca2 in zebrafish during early 
development and in the adult gonads.  Finally, we evaluated the applicability of long-
term controlled breeding experiments in zebrafish for modeling reproductive history 




Materials and Methods 
 
Histologic evaluation and staging of adult wildtype zebrafish ovaries and testes.  
Adult wildtype AB* male and female zebrafish were euthanized in an overdose of 
0.4% Tricaine Methanesulfonate, fixed overnight in 4% Paraformaldehyde (PFA; 
Boston Bioproducts, Ashland, MA), and transferred to 70% ethanol.  Sections were 
routinely processed for preparation of Hematoxylin and Eosin (H & E) sections 
(Histoserv Inc., Gaithersburg, MD).  Ovarian (73) and testicular (76) morphology and 
development were staged as described. 
 
Immunohistochemistry for cytokeratin expression in zebrafish, rabbit, macaque, and 
human ovaries.   Adult wildtype AB* female zebrafish were euthanized and fixed as 
described.  Sections were routinely processed for paraffin embedding and sectioning 
(Histoserv Inc.).  Paraffin-embedded blocks containing formalin-fixed rabbit and 
macaque ovary specimens were provided by Dr. Matthew Starost (Veterinary 
Diagnostic and Research Services, NIH).  Unstained sections of formalin-fixed, 
paraffin-embedded normal human ovarian tissue were acquired from an archive of 
human tissues (Laboratory of Pathology, NCI, NIH).   Unstained sections from each 
species were routinely processed for immunohistochemistry by Histoserv Inc. 
(Appendix II) with a mouse monoclonal anti-cytokeratin specific for the Type II 
cytokeratins 1, 5, 6, and 8 (1:150; Clone PCK-26, Sigma-Aldrich, St. Louis, MO). 
 
Construction of RNA probes for zebrafish brca2.  Three plasmids were constructed 




hybridization (WISH) and in situ hybridization (ISH): pBSII-SK+/brca2-ex27, pBSII-
SK+/brca2-3’, and pBSII-SK+/brca2-5’.  The pBSII-SK+/brca2-ex27 plasmid 
contained a 330 bp fragment of zebrafish brca2 genomic DNA.  Primers created 
HindIII and XbaI restriction sites on the ends of the PCR product.  The pBSII-
SK+/brca2-3’ plasmid contained a 3828 bp fragment from the 3’ end of zebrafish 
brca2 cDNA.  The reverse primer created a NotI restriction site at the 3’ end of the 
PCR product.  The pBSII-SK+/brca2-5’ plasmid contained a 2484 bp fragment from 
the 5’ end of zebrafish brca2 cDNA.  The forward primer created a SalI restriction 
site on the 5’ end of the PCR product.  The primer sequences used for plasmid 
constructs are given in Appendix III. 
 
Each insert was amplified by PCR and cloned into pBSII-SK+.  For pBSII-
SK+/brca2-ex27, the insert and pBSII-SK+ were digested with HindIII and XbaI.  For 
pBSII-SK+/brca2-3’, the insert and pBSII-SK were digested with NotI and BamHI 
(this insert had a naturally occurring BamHI restriction site at the 5’ end).  For pBSII-
SK+/brca2-5’, the insert and pBSII-SK+ were digested with SalI and BamHI (this 
insert had a naturally occurring BamHI restriction site at the 3’ end).  After restriction 
digestion, inserts and plasmids were gel-purified with a QIAquick Gel Extraction Kit 
(QIAGEN, Valencia, CA) according to the manufacturer’s protocol.  Inserts and 
plasmids were ligated with T4 DNA ligase (Invitrogen, Carlsbad, CA) according to 
the manufacturer’s protocol, and ligation reactions were used to transform DH5- 
chemically competent E. coli (Invitrogen) according to the manufacturer’s protocol.  





For each construct, 2 g of plasmid DNA were linearized and purified (PCR 
Purification Kit; QIAGEN) according to the manufacturer’s protocol.  Antisense and 
sense RNA labeled with Digoxigenin (DIG) were transcribed using DIG RNA 
Labeling Mix and T7 or T3 RNA polymerases (Roche, Mannheim, Germany) 
according to the manufacturer’s protocol.  After transcription, DIG-labeled RNA was 
treated with 0.05U/l RNase-free DNase I (Invitrogen) and ethanol-precipitated.  
RNA quantity and quality were assessed by absorbance at 260 nm and by RNA-
denaturing formaldehyde gel electrophoresis. 
 
Embryo collection and processing for WISH.  Embryos were collected from incrosses 
of wildtype AB* zebrafish and staged according to Kimmel et al. (113).  
Approximately 50 embryos were collected at each of the following time points:  0.75 
hours post fertilization (hpf) (2-cell); 2.75 hpf (mid-blastula); 6 hpf (shield); 11 hpf 
(early somitogenesis); 15 hpf (late somitogenesis); and 24 hpf (pharyngula).  
Embryos were washed twice with 1X PBS, fixed in 4% PFA overnight at 4C, and 
washed twice with 1X PBS.  Embryos collected after gastrulation (11, 15, and 24 hpf) 
were anesthetized with 0.4% Tricaine Methanesulfonate in blue water before fixation.   
 
WISH for brca2.  Fixed embryos were incubated in 100% methanol at -20C 
overnight, washed with 100% acetone, and rehydrated with a series of methanol/1X 
PBS grades.  Embryos were prehybridized in WISH hybridization buffer at 60C for 




buffer containing either antisense or sense DIG-labeled RNA for zebrafish brca2 (1 
ng/l) overnight at 60C.  Following hybridization, embryos were washed in the 
following series of washes:  Wash I (60C), Wash II (60C), Wash III (60C), Maleic 
Acid Buffer (room temperature).   For blocking, embryos were incubated in WISH 
blocking solution for one hour.  Embryos were incubated with WISH working 
antibody solution containing anti-DIG-AP antibody (1:5000; Roche) for two to three 
hours.  Following antibody incubation, embryos were serially washed in PBTw buffer 
and washed twice in staining buffer.  For detection, embryos were incubated in BM 
Purple substrate (Roche) for a minimum of five hours at room temperature or at 37C.  
Embryos were then washed in 1X PBS, fixed overnight in 4% PFA, and stored in 1X 
PBS.  brca2 expression in wildtype AB* zebrafish embryos was analyzed in three 
independent experiments, each with 50 embryos per stage.  The composition of 
reagents used in WISH experiments are given in Appendix IV.   
 
ISH for brca2.  Wildtype AB* zebrafish were euthanized and fixed as described 
above.  Unstained 5m sections were prepared under RNase-free conditions 
(Histoserv Inc.).  Unstained sections were deparaffinized with Histoclear (Sigma-
Aldrich) and rehydrated with a series of ethanol grades.  Sections were incubated in 
proteinase K (5 g/ml; Fermentas Inc., Glen Burnie, MD) in 1X PBS at 37C and 
post-fixed in 4% PFA.  Sections were incubated in 0.1M Triethanolamine 
Hydrochloride/0.25% Acetic Anhydride solution and subsequently dehydrated in a 
series of ethanol grades.  Sections were prehybridized in ISH hybridization buffer for 




with either antisense or sense DIG-labeled RNA for zebrafish brca2 (400 ng/ml or 
800 ng/ml) at 55C or 60C overnight.  Following hybridization, sections were 
washed three times in 50% Formamide/50% 2X SSC at 55C or 60C, and 
subsequently passed through a series of 2X SSC and block buffer washes.  Sections 
were incubated in ISH blocking solution or 1X Blocking Solution (5X In Situ 
Hybridization Blocking Solution; Vector Laboratories Inc., Burlingame, CA) for 
thirty minutes at room temperature and incubated in ISH working antibody solution 
containing anti-DIG-AP antibody (1:500; Roche) for two hours at room temperature.  
Following antibody incubation, sections were washed with block buffer and color 
buffer washes.  For detection, sections were incubated in BCIP/NBT working 
solution (BCIP/NBT AP Substrate Kit; Vector Laboratories Inc.) for a minimum of 
two to three hours.  Sections were then washed in stop buffer, briefly dehydrated in 
an ethanol grade series, air-dried, and coverslipped with Permount (Fisher Scientific, 
Pittsburg, PA).  Staging of gonads after ISH was performed as described (73, 76), and 
brca2 expression in gonads was analyzed in at least three independent experiments.  
The composition of reagents used in ISH experiments are given in Appendix IV. 
 
Zebrafish breeding experiments.  Embryos were collected from an incross of wildtype 
AB* zebrafish and raised to adulthood.  At three months of age, zebrafish were 
organized into the following cohorts:  breeding females (n = 16), breeding males (n = 
16), nonbreeding females (n = 18), and nonbreeding males (n = 18).  Breeding 
zebrafish were bred once every two weeks, and were generally set up as pairs in 




female zebrafish was scored by assessing the approximate number of eggs produced, 
and results were recorded as relative egg production per female with the following 
scale:  0, no eggs laid; 1, < 50 eggs laid; 2, 50 – 100 eggs laid; 3, > 100 eggs laid.  At 
six-month intervals from the onset of breeding experiments, four adults from each 
cohort were collected, euthanized, and fixed as described above (Appendix V). 
 
Embryo imaging.  Embryos were imaged in glycerol/1X PBS solution with a Leica 
MZ16 stereomicroscope and camera (Leica DFC420) with Leica Imaging Suite.  
Images were minimally processed with Adobe Photoshop Version 10.0.1. 
 
Imaging of zebrafish sections.  Histologic sections were imaged with an Olympus 
BX41 and camera (Diagnostics Instruments 14.2 color mosaic) with SPOT software 
(Version 4.6.4.3, 1997-2006). Images were minimally processed with Adobe 
Photoshop Version 10.0.1. 
 
Results 
Cell populations are conserved between mammalian and zebrafish gonads. 
Histologic analyses of gonads from adult wildtype zebrafish demonstrated that the 
basic structural organization and cell populations observed in zebrafish ovary and 
testis were similar to adult mammalian gonads.  In the zebrafish ovary, germ cell 
stages identified histologically included oogonia, stage I oocytes, stage II oocytes, 






Fig. 2.1 Wildtype zebrafish ovary and testis.  (A) The ovary contains developing 
oogonia and developing oocytes; stage II and III oocytes are enveloped by follicular 
epithelium, and the ovary is covered by the ovarian surface epithelium.  (B) The testis 
is composed of tubules containing spermatogonia, primary spermatocytes, secondary 
spermatocytes, and spermatozoa; PSC and SSC develop in spermatocysts surrounded 
by Sertoli cells. I, stage I oocyte; II, stage II oocyte; III, stage III oocyte; OG, 
oogonia; FE, follicular epithelium; OSE, ovarian surface epithelium; TB, tubule; SG, 
spermatogonia; PSC, primary spermatocytes; SSC, secondary spermatocytes (not 
shown); SPT, spermatids; SZ, spermatozoa; ST, Sertoli cells.  Scale bars, 200 µm (A, 






embedded in the ovarian stroma and exhibited small amounts of dark eosinophilic 
cytoplasm and a small dark basophilic nucleus.  Stage I oocytes exhibited moderately 
abundant, pale to dark basophilic cytoplasm, and large amphophilic nuclei with one 
or more prominent nucleoli.  Stage II oocytes had abundant basophilic cytoplasm 
containing numerous clear to pale eosinophilic vacuoles, and large eosinophilic nuclei 
with peripheralized chromatin.  Stage III oocytes exhibited abundant cytoplasm filled 
with eosinophilic globular material (yolk protein (73)), and a large eosinophilic 
nucleus with peripheralized chromatin.  Stage II and stage III oocytes exhibited a rim 
of brightly eosinophilic material subjacent to the cellular margin (vitelline envelope 
(73)).  Stage II and II oocytes were surrounded by a single layer of epithelial cells 
forming the follicular epithelium (Fig. 2.1A).  The ovarian surface epithelium formed 
a flattened single cell layer overlying the ovary (Fig. 2.1A).   
 
In the zebrafish testis, germ cell stages identified histologically included 
spermatogonia, type I spermatocytes, type II spermatocytes, spermatids, and 
spermatozoa (Fig. 2.1B).  Spermatogonia were present individually or in small 
clusters at the junctions of testicular tubules, and had eosinophilic cytoplasm and 
large basophilic nuclei.  Primary spermatocytes were present in defined clusters along 
the margins of tubules, and had prominent basophilic nuclei and scant cytoplasm.  
Secondary spermatocytes were infrequently observed; while similar to primary 
spermatocytes in organization and cytological characteristics, secondary 
spermatocytes were approximately half the size of primary spermatocytes and often 




along the margins of tubules, and exhibited small, dark basophilic nuclei and 
inapparent cytoplasm.  Spermatozoa formed dense clusters in the centers of tubules, 
and had small, dark basophilic nuclei and inapparent cytoplasm.  Clusters of 
spermatocytes were delineated by Sertoli cells, which exhibited flattened, elongated 
eosinophilic cytoplasm and small, dark basophilic nuclei (Fig. 2.1B). 
 
Pancytokeratin immunoreactivity is conserved in ovarian surface epithelium.   
Human ovarian surface epithelium (OSE) expresses keratin types 7, 8, 18, and 19, 
which is characteristic of simple epithelia (8).  To determine if cytokeratin expression 
in OSE is conserved among mammalian and zebrafish species, sections of normal 
ovary from human, macaque, rabbit, and zebrafish were evaluated for 
immnunohistochemical detection of Type II cytokeratins (keratins 1, 5, 6, and 8).  
Human (accession NP_00226.41) and zebrafish (accession NP_956374.1) keratin 8 
are 79% identical.  This antibody was selected because the manufacturer indicated 
that it exhibits cross-reactivity across a variety of species.  Immunohistochemistry for 
cytokeratins on ovary specimens demonstrated strong, specific cytokeratin 
immunoreactivity in the OSE from each species (Fig 2.2).  
 
brca2 is ubiquitously expressed during embryogenesis in wildtype zebrafish embryos. 
WISH for brca2 on wildtype AB* embryos from the 2-cell stage through 24 hours 
post-fertilization (hpf) indicated that brca2 was abundantly expressed in early 





Fig. 2.2 Pancytokeratin expression is conserved in zebrafish OSE.  (A) Ovarian 
surface epithelium (OSE) from human, macaque, rabbit, and zebrafish ovary with 
normal ovarian morphology.  (B) The OSE from each species shows specific 
pancytokeratin immunoreactivity.  Sections were counterstained with Hematoxylin.  
(C) Negative controls (secondary antibody only).  Sections were counterstained with 





Fig. 2.3 brca2 expression in wildtype zebrafish embryos.  WISH for brca2 
expression in zebrafish embryos with antisense (AS, top panels) and sense (S, bottom 
panels) probes at the indicated stages demonstrates expression of brca2 throughout 




 during oogenesis (114).  At 24 hpf, brca2 was highly expressed in the developing
brain, eye, and ear, with highest expression in the subventricular regions and the 
developing retina (Fig. 2.3). 
 
brca2 is expressed in the CNS of zebrafish larvae and the immature gonad of juvenile 
zebrafish.  
WISH for brca2 on wildtype AB* larvae at 2 days post fertilization (dpf) through 5 
dpf demonstrated that brca2 expression was maintained in the developing eye, ear, 
and subventricular regions of the CNS (Fig. 2.4).  There was an overall decline in the 
intensity of brca2 expression as maturation progressed (Fig. 2.4).  At 4 dpf and 5 dpf, 
some zebrafish larvae exhibited brca2 expression in the developing intestinal tract 
(Fig. 2.4, arrows). 
 
ISH for brca2 in sections of gonads from 30 dpf wildtype AB* zebrafish showed 
brca2 expression in putative premeiotic germ cells and perinucleolar oocytes (Fig. 
2.5). brca2 was not expressed in less mature germ cells and was not detected in other 
tissue types (data not shown). 
 
brca2 is expressed in adult zebrafish gonads.   
ISH for brca2 in wildtype zebrafish ovaries showed brca2 expression in developing 





Fig. 2.4 brca2 expression in wildtype zebrafish larvae.  WISH for brca2 expression 
in zebrafish larvae with AS and S probes at 2 dpf (A), 3 dpf (B), 4 dpf (C), and 5 dpf 
(D) demonstrates expression of brca2 in the developing eye, ear, and CNS.  brca2 





Fig. 2.5 brca2 expression in wildtype juvenile zebrafish gonads.  ISH for brca2 
expression in serial sections of juvenile gonads with AS (middle panel) and S (lower 
panel) probes shows that brca2 is expressed in perinucleolar oocytes (arrows) and in 
putative premeiotic germ cells (arrowheads).  An H&E serial section of juvenile 





Fig. 2.6 brca2 expression in adult zebrafish gonads.  In situ hybridization for brca2 
expression in serial sections of adult zebrafish ovary with AS (middle panels) and S 
probes (right panels) indicates that brca2 is expressed in oocytes (A), follicular 
epithelium (B), and ovarian surface epithelium (C).  In situ hybridization for brca2 
expression in serial sections of adult zebrafish testis (D) indicates that brca2 is 
expressed in spermatogonia and spermatocytes (arrows).  Hematoxylin and eosin 
sections of ovary and testis (left panels) are provided for anatomic reference.  I, stage 
I oocyte; II, stage II oocyte; III, stage III oocyte; FE, follicular epithelium; OSE, 
ovarian surface epithelium; SG, spermatogonia; SC, spermatocytes; SZ, spermatozoa.  




brca2 was additionally expressed in the follicular epithelium (Fig. 2.6B) and the 
ovarian surface epithelium (Fig. 2.6C).   In adult wildtype testes, brca2 was expressed 
in spermatogonia and developing spermatocytes; mature spermatozoa did not express 
brca2 (Fig. 2.6D). 
 
Wildtype adult female zebrafish demonstrate disparate breeding histories.   
Analyses of breeding history and egg production demonstrated that individual 
wildtype female zebrafish can experience widely variable reproductive histories (Fig. 
2.7).  Among individual females, egg production ranged from none to greater than 
100 embryos produced per breeding cycle.  Failure of egg production was often 
intermittent, and some females would remain infertile for up to 14 weeks before 
resuming egg production.  Variability in breeding history was more pronounced with 
increased age.  During these studies, one breeding female zebrafish died unexpectedly 
after 10 months of breeding; thus, this female’s breeding history was not included in 
analyses of egg production.  Histologic examination of the ovaries from this female 
zebrafish revealed chronic granulomatous oophoritis with fibrosis and retention of 





Figure 2.7 Relative egg production among wildtype female zebrafish.  Wildtype 
female zebrafish were bred at biweekly intervals for 6 months (A), 1 year (B), 1.5 
years (C), and 2 years (D).  Relative egg production for individual females was scored 
as follows:  0, no eggs laid; 1, < 50 eggs laid; 2, 50 – 100 eggs laid; 3 > 100 eggs laid.  





These studies were designed to evaluate the zebrafish as a model for studying gonadal 
pathophysiology and brca2.  Initial analyses focused on examining normal gonadal 
morphology in the zebrafish.  Observations of germ cell development and stromal cell 
populations in wildtype AB* zebrafish ovaries and testes were similar to previous 
studies of zebrafish gonadal morphology (73, 75, 76).  While ovarian thecal cells and 
testicular Leydig (interstitial) cells were not readily identifiable in routine histologic 
sections, these cell populations have been identified by other methods in zebrafish 
gonads (73, 75, 76).  These studies indicate that germ cell and somatic cell 
populations with conserved intracellular structural organization are identifiable by 
routine histology in zebrafish ovaries and testes.   
 
While no tissue-specific markers for the ovarian surface epithelium have been 
identified, expression of keratins 7, 8, 18, and 19 is characteristic of this tissue (8). 
Immunohistochemistry for type II cytokeratins, which include keratin 8, 
demonstrated that pancytokeratin immunoreactivity in the ovarian surface epithelium 
is conserved across multiple species, including zebrafish.  These findings are an 
additional indication that ovarian structure is similar in zebrafish as compared to other 
species.   These histologic and immnunohistochemical studies in wildtype AB* 






The ovarian cancer susceptibility gene BRCA2 has been extensively investigated in 
mouse models after a link between BRCA2 mutation and ovarian cancer was first 
discovered in 1994 (28).  Evaluations of Brca2 expression in mouse embryos from 
day 6.5 to day 19 indicate that Brca2 is strongly expressed during embryogenesis 
(115-117).  Brca2 expression is most abundant in rapidly dividing tissues, including 
the ventricular zone, neuroepithelium of the eye, walls of the cerebral hemispheres, 
and other tissues (115-117). 
 
In preparation for establishing a brca2-mutant zebrafish line, brca2 expression during 
embryogenesis was evaluated.  The data presented herein demonstrate that in 
zebrafish, brca2 is strongly expressed throughout early embryogenesis from the two-
cell stage up to 24 hpf.  These findings complement a previous study of brca2 
expression during zebrafish embryogenesis (118).  As development progresses 
beyond 24 hpf, brca2 expression is maintained in the developing CNS, eye, and 
intestine.  Regions of highest expression in zebrafish are similar to those described in 
mice (115-117), indicating that the pattern of BRCA2 expression is conserved 
between mammalian and zebrafish embryos. 
 
Importantly, brca2 is strongly expressed at the two-cell stage, well before the onset of 
zygotic gene transcription in cleavage cycle ten (~ 1000 cell stage, ~ 3 hpf) (119). 
Thus, maternally provided brca2 is available for DNA repair before zygotic 
transcription begins.  In contrast, the highest levels of Brca2 expression in mice 




embryos begins before implantation at the 1 – 2 cell stage (120, 121), the majority of 
Brca2 RNA present during mouse embryogenesis is likely to be derived from the 
zygotic genome, rather than provided maternally. 
 
To build upon these studies of brca2 in zebrafish embryos, developing and adult 
zebrafish were evaluated for brca2 expression by ISH.  In juvenile and adult 
zebrafish, brca2 expression was restricted to the gonads.  Juvenile wildtype zebrafish 
expressed brca2 in putative premeiotic germ cells and perinucleolar oocytes; brca2 
expression was not detected in less mature germ cells.  In zebrafish, meiosis begins in 
a subset of the germ cell population during gonadal development (77, 122).  BRCA2 
is required for repair of planned double-strand DNA breaks generated during meiotic 
recombination, which occurs in prophase I (34, 58).  Thus, brca2 expression in germ 
cells entering meiosis in the juvenile zebrafish gonad is compatible with the known 
function of BRCA2 in meiotic prophase. 
 
Adult wildtype female zebrafish expressed brca2 in both germ cell and somatic cell 
populations in the ovary.  Oocytes expressed brca2 throughout oogenesis, with 
accumulation of abundant brca2 in the most mature oocytes.  Expression of brca2 in 
mature oocytes corresponds to the high levels of brca2 expression observed in early-
stage zebrafish embryos.  In addition, brca2 is expressed in the follicular epithelium 
and the ovarian surface epithelium.  Studies of Brca2 expression in mouse ovaries 
have demonstrated similar expression patterns in the ovarian surface epithelium and 





In adult wildtype male zebrafish, brca2 is expressed in spermatogonia and in primary 
and secondary spermatocytes.  Zebrafish spermatogenesis is comparable to 
spermatogenesis in mammalian species; primary spermatocytes, which can be 
identified by their size and nuclear morphology, are in meiotic prophase of the cell 
cycle (75).  Thus, brca2 expression in zebrafish primary spermatocytes correlates 
with meiotic progression. These findings are similar to studies of Brca2 expression in 
mouse testes, which demonstrate that Brca2 is expressed during spermatogenesis, 
especially in spermatocytes in meiotic prophase (116).  In humans, BRCA2 localizes 
to unsynapsed regions of meiotic chromosomes in human spermatocytes (123).  Both 
zebrafish and mice exhibit Brca2 expression in populations of cells that are 
mitotically active (116), but are not in meiosis, which may indicate additional 
requirements for Brca2 in DNA repair during spermatogenesis.   
 
Studies of brca2 expression during embryogenesis and in juvenile and adult zebrafish 
demonstrated that patterns of expression are conserved between zebrafish and mice.  
This may reflect similar functions for brca2 during development and in adult gonads 
in these species, an important consideration for comparative models.  In addition, 
these findings will be important for analyzing the effects of brca2 mutation in 
zebrafish. 
 
Analyses of breeding history over a two-year period in wildtype female zebrafish 




females, particularly with increasing age.  The occurrence of granulomatous 
oophoritis, which was observed in one zebrafish from the breeding group that died 
during the study, is a recognized problem of uncertain etiology among breeding 
female zebrafish (124), and may have contributed to intermittent or sustained 
infertility in this population of females.  These studies indicate that reproductive 
history as a risk factor for ovarian cancer is not easily evaluated by comparing 
individual zebrafish.  Analyzing reproductive history among large groups of 
zebrafish, rather than performing relative comparisons within a group, could possibly 
diminish the effects of individual biologic variability. 
 
The morphologic, immunohistochemical, and in situ hybridization studies presented 
in this chapter demonstrate that the zebrafish is a feasible animal model for studying 
comparative gonadal pathophysiology and the role of brca2 in embryogenesis, 
development, and tumorigenesis.  The abundant maternal RNA for brca2 present in 
early embryogenesis suggests that maternally provided brca2 could sustain brca2-
mutant zebrafish embryos.  This would circumvent the early embryonic lethality that 
occurs in most Brca2-mutant mouse models and facilitate establishment of a brca2-




Chapter 3: Generating and characterizing a brca2-mutant zebrafish line 
Introduction 
The identification and establishment of knockout models in zebrafish have 
traditionally involved forward genetic screens of mutagenized zebrafish (125).  More 
recently, a variety of techniques have evolved that allow identification and 
establishment of zebrafish lines with mutations in specific genes of interest.  
Ethylnitrosourea (ENU)-mutagenized libraries of zebrafish DNA and cryopreserved 
sperm provide an important resource for generating mutant zebrafish lines (63-67).  
Unique ENU-induced mutations have been identified in a number of cancer 
susceptibility genes in zebrafish, leading to the generation of zebrafish models for 
mutations in tp53, apc, and rag1, among others (69-71). 
 
In this chapter, a brca2-mutant zebrafish line derived from an ENU-mutagenized 
library is characterized.  This zebrafish line carries a nonsense mutation in brca2 exon 
11 (brca2
Q658X
), a mutation similar in location and type to BRCA2 mutations in 
humans with hereditary breast and ovarian cancer (17).  Analyses of the brca2
Q658X
 
mutation in zebrafish demonstrate the impact of brca2 mutation on embryonic 
survival, development, gonadogenesis, and sexual differentiation.  Strikingly, these 





Materials and Methods 
Identification and establishment of a brca2-mutant zebrafish line.  A previously-
established ENU-mutagenized library (68) was screened by PCR and sequencing with 
overlapping primer pairs spanning zebrafish brca2 exon 11.  Sequence data was 
analyzed with PolyPhred (http://droog.gs.washington.edu/polyphred/), and a zebrafish 
line carrying a C to T point mutation that produces a glutamine (Q) to stop codon (X) 
change was identified.  The mutant line was recovered by in vitro fertilization (IVF) 
as previously described (68). Following recovery by IVF, brca2
Q658X
 heterozygous 
zebrafish were outcrossed to wildtype EK or AB* zebrafish.  The brca2
Q658X
 mutant 
line is referenced in the Zebrafish Model Organism Database (ZFIN) with mutant 
allele designation brca2
hg5
.   
 
Genotyping for the brca2
Q658X
 mutation.  Zebrafish were anesthetized in 0.4% 
Tricaine Methanesulfonate in system water and a portion of the caudal fin was 
clipped.  Fin tissue was digested in 100µl of DNA extraction buffer with 0.2mg/ml 
proteinase K (Fermentas Inc.) at 50 – 55ºC for a minimum of two hours followed by 
ten minutes at 95ºC.  The dCAPS-Finder 2.0 program (126) was used to design 
primers to detect the brca2
Q658X
 point mutation.  These primers amplified a 379 bp 
fragment of brca2 and created an AluI restriction site based on the presence of the 
brca2
Q658X
 point mutation.  PCR products were incubated with AluI digestion buffer 
(0.07 U/µl AluI in 1X Tango buffer; Fermentas Inc.) at 37ºC for a minimum of two 
hours.  Digested PCR products were analyzed by gel electrophoresis (2.5% agarose in 





Establishing a dose curve for gamma-irradiation of zebrafish embryos.  Embryos 
from incrosses of wildtype AB* zebrafish were collected.  At approximately 4.5 
hours post-fertilization (hpf), zebrafish embryos were placed in 4 ml blue water 
media (NaCl, 0.57g/L; Methylene Blue, 0.002%),  in 60 mm  Petri dishes and were 
irradiated with an Eldorado 8 Cobalt-60 Teletherapy machine (MDS Nordion, 
Ottawa, Ontario, Canada, formerly AECL Ltd). The dose rate varied from 140-150 
cGy/min during the course of this study.  Decay corrections were done monthly, and 
full electron equilibrium was ensured for all irradiations.  Zebrafish embryos received 
the following dosages:  0 Gy, 0.1 Gy, 0.5 Gy, 1.0 Gy, 5.0 Gy, 10.0 Gy, and 20.0 Gy.  
Sixty embryos were irradiated at each dose interval. 
 
Acridine Orange assay for apoptosis analyses in vivo.  Embryos were dechorinated 
by hand at 24 hpf, soaked in Acridine Orange (Sigma; 2 µg/ml in blue water) for 30 
minutes at 28.5°C, and washed twice in blue water.  Live embryos were anesthetized 
with 0.4% Tricaine Methanesulfonate and evaluated for Acridine Orange staining 
with a Zeiss Stemi SV11Apo stereomicroscope.  Images were captured with Openlab 
modular imaging software (Improvision/Perkin Elmer Inc.) and minimally processed 
with Adobe Photoshop Version 10.0.1. 
 
Irradiation and apoptosis analyses of embryos collected from incrosses of brca2
Q658X
 
heterozygotes. Embryos were collected from incrosses of brca2
Q658X
 heterozygotes.  




0 Gy, 1.0 Gy, and 5.0 Gy.  Embryos were evaluated for apoptosis by Acridine Orange 
staining and imaged as described previously. 
 
Phenotypic analysis of adult brca2-mutant zebrafish.  Adult zebrafish collected from 
incrosses of brca2
Q658X
 heterozygous zebrafish were evaluated both grossly and 
histologically. Zebrafish were euthanized and fixed as described in Chapter 2.  
Specimens were routinely processed for paraffin embedding and preparation of 5µm 
H & E sections (Histoserv Inc.).  
 
Assessment of meiotic progression in testes from adult male zebrafish. Testes from 
ten adult males (5.5 months of age) of each genotype were dissected and grouped by 
genotype for fixation as described in Chapter 2.  To determine the total percentage of 
spermatocysts containing cells in meiosis, five tubules were randomly selected from 
each of ten testis sections for a total of fifty tubules.  Tubules in which the tubular 
lumen and margins could not be reasonably ascertained were disregarded, and 
sections without at least five well-defined tubules in cross section were not included.  
For each tubule, the total number of spermatocysts was counted and the number of 
spermatocysts containing spermatocytes with meiotic figures was recorded (Table 
3.1).  The numbers of spermatocysts per tubule from testes of each brca2 genotype 
were compared by unpaired t-tests (Table 3.1).  The numbers of meiotic 
spermatocysts per tubule from testes of each brca2 genotype were compared by 





Assessment of apoptosis in adult zebrafish testes by TUNEL assay.  5 µm unstained 
sections of testes from ten adult males (5.5 months of age) of each genotype were 
used for TUNEL labeling with a commercially available kit (In Situ Cell Death 
Detection Kit, AP; Roche).  After TUNEL labeling, sections were counterstained with 
Nuclear Fast Red Solution (Sigma-Aldrich Co.) and mounted with Clear-Mount 
(Electron Microscopy Services, Hatfield, PA).  TUNEL assays were performed with 
each sample set in three independent experiments. 
 
Assessment of apoptosis in adult zebrafish testes by caspase-3 immunohistochemistry.  
5 µm unstained sections of testes from ten adult males (5.5 months of age) of each 
genotype were deparaffinized in xylene and rehydrated through a series of ethanol 
grades.  Sections were incubated in 3% H2O2/70% methanol to block endogenous 
peroxidase activity.  For antigen retrieval, sections were incubated in 1X DAKO 
Target Retrieval Solution with steam (DAKO, Glostrup, Denmark).  DAKO Protein 
Block and normal goat serum were used for blocking.  Endogenous biotin activity 
was blocked with a commercially available kit (Vector Laboratories Inc.).  For 
detection of cleaved caspase-3, a rabbit polyclonal anti-cleaved caspase-3 antibody 
(1:200 dilution; Cell Signaling, Boston, MA) was used with a goat anti-rabbit 
biotinylated secondary antibody (1:400 dilution; DAKO).  Detection was achieved by 
incubating sections with a preformed avidin:biotinylated enzyme complex (Vectastain 
ABC Kit; Vector Laboratories Inc.) followed by application of 3,3’-diaminobenzidine 




were counterstained with Mayer’s Hematoxylin Solution (Sigma-Aldrich Co.), 
dehydrated, and coverslipped. 
 
Histologic analysis of gonadal development.  Juvenile zebrafish were collected at 21, 
31, 41, and 51 days post fertilization (dpf), euthanized, genotyped, and fixed as 
described in Chapter 2, and specimens were grouped in tissue cassettes by genotype.  
21 dpf juveniles were embedded in 2% agarose prior to placement in tissue cassettes. 
Juvenile gonad development was staged as described (77, 78).  Ten sections were 
screened per group; specimens were assessed for the presence of gonadal tissue, 
presence of identifiable perinucleolar oocytes in gonads (signifying juvenile ovary 
formation), presence of spermatogonia in spermatogonial cysts (signifying testicular 






-mutant zebrafish are viable.  
 To establish a brca2-mutant zebrafish model, we screened an Ethylnitrosourea 
(ENU)-mutagenized library for mutations in brca2 exon 11 (Fig. 3.1).  We identified 
a zebrafish line carrying a C to T point mutation that produces a glutamine (Q) to stop 
codon (X) change (Fig. 3.2A).  The brca2
Q658X
 mutation was routinely detected by 
PCR and restriction digestion; the PCR product from the brca2
Q658X
 mutant allele 
migrates at a lower molecular weight than the wildtype allele (Fig. 3.2B).  Embryos 
collected from incrosses and outcrosses of brca2
Q658X





Fig. 3.1 Screening an ENU-mutagenized library for mutations in brca2 exon 11.  
A previously established ENU-mutagenized library was screened for mutations in 
exon 11 of zebrafish brca2 by PCR and sequencing.  Overlapping primer sets 







 mutant zebrafish line.  (A) Schematic of zebrafish brca2 (upper) 
compared to human BRCA2 (lower).  Red bars represent the Rad51-binding BRC 
repeats and the dark blue box represents the DNA binding domain.  The zebrafish 
brca2
Q658X
 mutation (C1971T;Q658X) described herein is shown relative to its 
position within exon 11.  (B) The zebrafish brca2
Q658X
 mutation is identifiable by 
PCR and restriction digestion.  Gel electrophoresis resolves PCR products from the 
wildtype allele (344 bp, green arrowhead), mutant allele (318 bp, orange arrowhead), 
and undigested PCR product (379 bp, black arrowhead).  (C) Genotypes of progeny 
from incrosses of brca2
Q658X
 heterozygotes conform to expected Mendelian ratios.  
The percentages of observed genotypes were not statistically significantly different 
than expected (
2




phenotypically normal (data not shown).  Genotyping data collected on zebrafish 
derived from twelve different incrosses of brca2
Q658X
 heterozygous zebrafish yielded 
wildtype, heterozygous, and homozygous mutant zebrafish in expected Mendelian 
ratios, indicating that brca2
Q658X
 homozygotes were fully viable (Fig. 3.2C).
brca2
Q658X
 mutation is not associated with increased apoptosis in embryos following 
exposure to ionizing radiation.   
To determine the effects of brca2 mutation on DNA repair capacity in zebrafish, 
embryos from incrosses of brca2
Q658X
 heterozygotes were exposed to ionizing 
radiation during early embryogenesis.  To establish an irradiation dose curve, 
wildtype zebrafish embryos were exposed to ionizing radiation over the following 
range: 0 Gy, 0.1 Gy, 0.5 Gy, 1.0 Gy, 5.0 Gy, 10.0 Gy, and 20.0 Gy.  After irradiation, 
embryos were evaluated for morphologic defects and for apoptosis in vivo by 
Acridine Orange staining (Appendix VI).  
 
Irradiation doses of 0 Gy, 1.0 Gy, or 5.0 Gy were selected for irradiation of embryos 
from incrosses of brca2
Q658X
 heterozygotes because these doses induced relatively 
low levels of apoptosis in wildtype embryos, and might therefore reveal increased 
susceptibility to radiation-induced apoptosis in brca2
Q658X
-mutant embryos.  Cohorts 
of embryos from three separate clutches were exposed to 0 Gy, 1.0 Gy, or 5.0 Gy at 
approximately 4 – 5 hpf.  Apoptosis was evaluated in vivo by Acridine Orange 







-mutant zebrafish are not more susceptible to ionizing 
radiation.  Representative examples of embryos that were derived from incrosses of 
brca2
Q658X
 heterozygotes and exposed to ionizing radiation (0, 1.0 Gy, or 5.0 Gy) at 4 
– 5 hpf.  The total numbers of embryos derived from incrosses of brca2
Q658X
 
heterozygotes in each irradiation dose group are indicated at the left.  At 
approximately 24 hpf, irradiated embryos were stained with Acridine Orange to 
detect apoptotic cells in vivo.  Within each dose group, no significant differences in 
morphologic appearance or level of apoptosis were observed by visual inspection 




apoptosis were observed with increasing irradiation dose, no difference in distribution 
or intensity of Acridine Orange staining was apparent within dose groups.
A subset of embryos that exhibited decreased swimming behavior at 3 dpf after 
irradiation was sacrificed for genotyping.  No correlation was found between brca2 
genotype and reduced swimming behavior.   
 
Following in vivo analyses for apoptosis, embryos from each dosage group were 
raised to adulthood and monitored for approximately 1.5 years (0 Gy, n = 92; 1.0 Gy, 
n = 97; 5.0 Gy, n = 94).  During this period, a small number of zebrafish from these 
cohorts were found dead or were euthanized (Appendix VII).  These data did not 
reveal a pattern in morbidity or mortality associated with brca2 genotype or with 




-mutant zebrafish are phenotypically male and exhibit aberrant 
spermatogenesis.   
At sexual maturity, all brca2
Q658X
 homozygotes were phenotypically male, while 
wildtype and brca2
Q658X
 heterozygous cohorts both included similar ratios of male 
and female zebrafish (Fig. 3.4A).   brca2
Q658X
 homozygotes induced egg laying in 
fertile wildtype female zebrafish, but eggs collected from these crosses were 
unfertilized.  
 
Upon histologic examination of the gonads, adult wildtype and brca2
Q658X
 







 homozygous zebrafish are phenotypically male and exhibit 
aberrant spermatogenesis. (A) Wildtype and brca2
Q658X
 heterozygotes exhibit 
distinctly male or female phenotypes, while brca2
Q658X
 homozygotes are 
phenotypically male.  (B) Gonads from zebrafish of each genotype reflect observed 
male or female phenotypes in (A).  Spermatogenesis is complete in testes from 
wildtype and brca2
Q658X
 heterozygotes.  Testes from brca2
Q658X
 homozygotes contain 
only spermatogonia and primary spermatocytes.  Ovaries from wildtype and 
brca2
Q658X
 heterozygotes are similar and contain developing and mature oocytes.  SG, 
spermatogonia; SC, spermatocytes; SZ, spermatozoa; I, stage I oocyte; II, stage II 




with predicted sex based on physical features and behavior (Fig. 3.4A, B).  In 
comparison, brca2
Q658X
 homozygotes had only testes (Fig. 3.4B).  Spermatogenesis 
was arrested in testes from brca2
Q658X
 homozygotes, with only spermatogonia and
primary spermatocytes present (Fig. 3.4B).  Spermatogenesis was complete in testes 
from male wildtype and brca2
Q658X
 heterozygotes (Fig. 3.4B).  The ovaries from 
female wildtype and brca2
Q658X
 heterozygotes were morphologically similar, with 




-mutant zebrafish exhibit meiotic arrest and clonal apoptosis of 
spermatocytes in adult testes.  
To further analyze spermatogenesis in brca2
Q658X
 homozygotes, germ cell 
progression through meiosis was evaluated in sections of testes from adult male 
zebrafish of each genotype.  Testes from adult brca2
Q658X
 homozygotes had increased 
numbers of spermatocysts containing spermatocytes with meiotic nuclear morphology 
(Fig. 3.5A).   Quantitative analysis of meiotic spermatocysts revealed that meiotic 
progression was arrested in testes from brca2
Q658X
 homozygotes.  The numbers of 
spermatocysts containing spermatocytes in meiosis were statistically significantly 
higher in testes from adult brca2
Q658X
 homozygotes compared to testes from wildtype 
(p = 0.0026) and brca2
Q658X
 heterozygotes (p = 0.0009) (Table 3.1).  
 
Meiotic arrest in adult brca2
Q658X
 homozygotes testes was accompanied by extensive 
spermatocyte apoptosis; in contrast, apoptotic cells were rare in mature testes from 
wildtype and brca2
Q658X







 homozygous zebrafish exhibit meiotic arrest and apoptosis of 
spermatocytes. (A) Testes from wildtype, brca2
Q658X
 heterozygotes, and brca2
Q658X
 
homozygotes.  Spermatocytes in testes from brca2
Q658X
 homozygotes undergo 
chromatin condensation in preparation for meiosis, but further meiotic stages are not 
present.  (B) TUNEL staining of testes from wildtype, brca2
Q658X
 heterozygotes, and 
brca2
Q658X
 homozygotes.  Multiple clusters of apoptotic spermatocytes are present in 
testes from brca2
Q658X
 homozygotes (inset).  SC, spermatocyst; MSC, meiotic 













Table 3.1 Quantitative analysis of meiotic spermatocysts in zebrafish testes.  The 
numbers of meiotic spermatocysts were quantitated as a percentage of the total 
number of spermatocysts in 50 tubules from 10 zebrafish of each brca2 genotype.  
The numbers of spermatocysts per 50 tubules were compared between brca2 
genotypes by unpaired t-tests (GraphPad Software, 
www.graphpad.com/quickcalcs/ttest1.cfm).  The numbers of meiotic spermatocysts 
were compared among brca2 genotypes by unpaired t-tests with Welch’s correction 
(GraphPad Prism Version 5.0). 
brca2 genotype # spermatocysts 
per 50 tubules 
# meiotic spermatocysts 
per 50 tubules 
% of meiotic 
spermatocysts 










351 38 11% 
    






















immunohistochemistry for cleaved caspase-3 (Appendix VIII) on sections of testes 
demonstrated multiple apoptotic spermatocytes in adult brca2
Q658X
 homozygotes, 




-mutant zebrafish do not develop juvenile ovaries.   
To determine the stage at which brca2 mutation affects sexual differentiation, gonads 
from juvenile zebrafish of each brca2 genotype were examined by histology at 
intervals between 21 days and 51 days post fertilization (dpf).  During this period, all 
zebrafish normally develop “juvenile ovaries”, which contain gonocytes, early 
meiotic oocytes, and perinucleolar oocytes (77, 78).  With maturation, males undergo 
oocyte loss and proliferation of spermatogonia and spermatocytes, while oocyte 
proliferation and differentiation continues in females (77, 78). 
 
Gonad development in wildtype and brca2
Q658X
 heterozygotes was similar at all time 
points.  At 21 dpf, the gonads from zebrafish of both genotypes were undifferentiated 
and contained gonocytes and scant stroma (Fig. 3.6A). At 31 dpf, gonads were 
classified into four morphologic types:  undifferentiated (similar to gonads at 21 dpf); 
juvenile ovary; presumptive ovary; and presumptive testis (Fig. 3.6B).  Juvenile 
ovaries were distinguished by the presence of perinucleolar oocytes (Fig. 3.6B, short 
arrows).  Presumptive ovaries exhibited numerous enlarged oocytes, while 
presumptive testes exhibited developing spermatogonial cysts with reduction or loss 





Fig. 3.6 Failure of ovarian development occurs in brca2
Q658X
 homozygous 
zebrafish. (A) Gonads from wildtype, brca2
Q658X
 heterozygotes, and brca2
Q658X
 
homozygotes zebrafish are indistinguishable at 21 days post fertilization (dpf).  (B) At 
31 dpf, wildtype and brca2
Q658X
 heterozygotes exhibit juvenile ovaries, early 
testicular differentiation, or early ovarian differentiation, whereas brca2
Q658X
 
homozygotes exhibit only early testicular differentiation.  Perinucleolar oocytes in 
juvenile ovaries are indicated by short arrows.  Putative premeiotic germ cells are 
indicated by arrowheads.  (C, D) At 41 and 51 dpf, wildtype and brca2
Q658X
 
heterozygotes exhibit continued maturation of testes or ovaries, while brca2
Q658X
 
homozygotes exhibit only testicular development.  Go, gonocyte; sgc, spermatogonial 
cyst; oc, oocyte; sc, spermatocyst; I, stage I oocyte; II, stage II oocyte.  Scale bars, 50 




differentiation into ovaries or testes was apparent in wildtype and brca2
Q658X
 
heterozygotes (Fig. 3.6C, D).  
 
In contrast, oocyte differentiation was not observed in gonads from brca2
Q658X
 
homozygotes at any time point.  At 21 dpf, gonads from brca2
Q658X
 homozygotes
were similar to gonads from wildtype and brca2
Q658X
 heterozygotes (Fig. 3.6A).  At 
31 dpf, gonads from brca2
Q658X
 homozygotes were classified as undifferentiated or 
presumptive testes (Fig. 3.6B).  Presumptive testes contained germ cells and clusters 
of round cells encircled by somatic cells, consistent with developing spermatogonial 
cysts.  In gonads from some brca2
Q658X
 homozygotes, large cells with prominent 
nuclei and vacuolated cytoplasm were present (Fig. 3.6B, arrowheads); these cells 
may be premeiotic germ cells, and were not observed in gonads from wildtype or 
brca2
Q658X
 heterozygotes.  Unlike testes from wildtype and brca2
Q658X
 heterozygotes, 
few spermatocysts were observed in developing testes at 41 dpf in brca2
Q658X
 
homozygotes (Fig. 3.6C).  By 51 dpf, spermatocysts in testes from brca2
Q658X
 
homozygotes contained only spermatogonia and primary spermatocytes, and fewer 
spermatocysts were present compared to wildtype and brca2
Q658X
 heterozygotes (Fig. 
3.6D).  No perinucleolar oocytes were observed in developing gonads from 
brca2
Q658X





-mutant zebrafish line identified and established in these studies 




truncation of the brca2 protein.  This mutation is similar in location and type to 
humans with BRCA2 mutations (17), and thus this mutant zebrafish line is well suited 
for studying BRCA2-associated carcinogenesis.  In humans, the majority of 
pathologic mutations in BRCA2 are point mutations or small insertions or deletions 
that truncate the BRCA2 protein (3, 26).  When these mutations occur in the “ovarian 
cancer cluster region” of BRCA2 exon 11, epidemiologic evidence suggests an 
increased incidence of ovarian cancer relative to breast cancer in affected families 
(16, 29).   
 
Multiple incrosses of brca2
Q658X
 heterozygous zebrafish revealed that brca2
Q658X
 
homozygotes were viable.  This is in marked contrast to the majority of Brca2-mutant 
mouse models, in which homozygous Brca2 mutation is typically associated with 
early embryonic lethality (see Chapter 1, Table 1.2).  This difference may reflect the 
relatively late onset of zygotic gene transcription in zebrafish embryos, which begins 
in cleavage cycle ten (119).  Since maternal brca2 is abundant in early-stage zebrafish 
embryos (Chapter 2, Fig. 2.3), it is likely that maternal RNA sustains brca2
Q658X 
homozygotes during early development.   
 
Biallelic mutation or loss of BRCA2 in cultured cells is associated with increased 
sensitivity to DNA-damaging agents (31, 35).  Similarly, blastocyst explants derived 
from Brca2-mutant mouse embryos at embryonic day 3.5 are highly sensitive to 
irradiation (50).  BRCA2 is required for error-free repair of double-strand DNA 




loss of BRCA2 would be expected to reduce a cell’s capacity for DNA repair.  
Accordingly, BRCA2-deficient cells that are exposed to DNA-damaging agents 
exhibit numerous foci of unrepaired DNA and failure of RAD51 to colocalize to sites 
of DNA damage (30, 31, 35). 
 
We assessed the effects of DNA damage in brca2-mutant zebrafish embryos by 
exposing embryos from incrosses of brca2
Q658X
 heterozygotes to ionizing radiation 
during the mid-blastula stage.  Irradiated and nonirradiated embryos were 
subsequently screened in vivo for apoptosis.  There was no apparent difference in 
embryonic development or level of apoptosis among embryos from incrosses of 
brca2
Q658X
 heterozygotes after irradiation; further, no significant long-term effects 
were observed in these populations of zebrafish.  Several possibilities may address 
these findings.  Firstly, DNA repair is known to be highly efficient in zebrafish 
embryos (127).  Furthermore, zebrafish embryos exhibit accurate DNA repair through 
the process of nonhomologous end-joining (127), an alternate repair process for 
dsDNA breaks that is considered to be more “error-prone” in other animals (31, 128).  
Finally, brca2-mutant zebrafish are supplied with abundant maternal RNA for brca2.  
Thus, there may be sufficient levels of brca2 present through the mid-blastula stage 
for repair by homologous recombination to occur.  In combination, these factors may 
prevent brca2-mutant zebrafish embryos from experiencing higher levels of sustained 







 mutation did not induce an embryonic phenotype, studies of 
adult brca2
Q658X
 homozygotes demonstrate a conserved role for brca2 in zebrafish 
germ cell development and spermatogenesis.  BRCA2 is required in germ cells for 
repair of double-strand DNA breaks generated during prophase of meiosis I, with loss 
of BRCA2 resulting in meiotic arrest (58, 129).  In mice, Brca2 is expressed during 
spermatogenesis, especially during meiotic prophase (115, 116).  Similarly, brca2 is 
highly expressed in primary spermatocytes in wildtype zebrafish testes (Chapter 2, 
Fig. 2.6), which are in meiotic prophase (75).  Thus, incomplete spermatogenesis and 
meiotic arrest in testes from brca2
Q658X 
homozygotes are in accordance with these 
findings. TUNEL staining and cleaved caspase-3 immunoreactivity revealed 
extensive apoptosis in brca2
Q658X
 homozygous testes, with apoptotic spermatocytes 
frequently present in discrete clusters.  These findings appear to reflect apoptosis of 
spermatocyte clones, since zebrafish spermatocytes are clonally derived from a single 
germ cell and organized into discrete groups referred to as spermatocysts (75). 
 
Analyses of juvenile brca2-mutant zebrafish demonstrated that immature brca2
Q658X
 
homozygotes fail to form juvenile ovaries during the process of gonad development, 
in contrast to what is regularly observed in wildtype zebrafish (77, 78).  Thus, these 
studies reveal an important role for brca2 in ovarian development, raising questions 
about the participation of brca2 in primordial germ cell-stromal cell signaling in the 
immature gonad.  BRCA2 is also known as FANCD1, and is a member of the Fanconi 
anemia (FA) family of proteins that regulate DNA damage response and repair (43).  




patients with mutations in various FA genes, although these studies are limited (130).  
Hypogonadism and meiotic arrest in germ cells have been reported in mouse models 
with mutations in several FA genes, including a Brca2-deficient mouse model that 
was rescued with human BRCA2 (58, 131).  Similar findings are described in mice 
homozygous for hypomorphic Brca2 mutations (52, 54-56) and in rats with 
homozygous Brca2 mutation (59).   
 
Gonad development in brca2
Q658X
 homozygous zebrafish may be additionally 
influenced by disrupted meiosis, since meiotic progression in germ cells is 
characteristic of developing female gonads.  In wildtype animals, female germ cells 
initiate meiosis during embryogenesis, while male germ cells remain quiescent until 
sexual maturity (132, 133).  Thus, the temporal requirements for BRCA2 may differ 
in female versus male gonads (Appendix IX).  Stromal cells and germ cells interact in 
the immature gonad to induce or repress the onset of meiosis in female versus male 
animals, respectively, and these interactions are tied to ovarian or testicular 
differentiation (132, 134, 135).  brca2-deficient germ cells in the immature gonad are 
likely to be meiotically incompetent, similar to brca2-deficient germ cells in the adult 
zebrafish testes.  Therefore, failure of meiotic progression in brca2-deficient germ 
cells during development may promote testicular differentiation. 
 
Targeted mutations of meiosis-specific genes in mouse models, including genes 
Spo11, Mlh1, Msh5, and Dmc1, are associated with varying degrees of gonadal 




Interestingly, the point at which germ cell loss occurs and the degree of meiotic arrest 
in germ cells appears to influence the extent of ovarian dysgenesis.  Mutations in 
Msh5 and Dmc1, which cause total germ cell arrest early in prophase I and oocyte 
degeneration at birth, are generally associated with failure of follicle formation and 
gonadal degeneration (136, 137).  In comparison, some oocytes from Mlh1 mutant 
mice can progress beyond metaphase I, and these mice exhibit relatively normal 
folliculogenesis and ovarian morphology (137).  Interestingly, testicular degeneration 
is not typical of male mice with mutations in meiosis-specific genes, even though 
they experience germ cell loss (138).  From these observations, it has been suggested 
that germ cells are only required for maintenance of ovarian morphology, not 
testicular morphology (138).  While there does not appear to be a fundamental 
requirement for meiosis-specific genes in mammalian sex determination, these studies 
demonstrate nonetheless that meiotically competent primordial germ cells are 
important for proper gonadal morphogenesis. 
 
mlh1 is the only meiosis-specific gene that has been studied previously in zebrafish.   
MLH1 is required for synaptonemal complex formation in meiotic prophase (139).  
Zebrafish that are homozygous for the mlh1 mutation exhibit reduced germ cell 
development or germ cell arrest, reduced fertility, spermatocyte apoptosis, and 
inviable offspring with frequent aneuploidy (140).  Interestingly, both male and 
female mlh1-mutant zebrafish develop, and some fertile zebrafish of both sexes are 
described (140, 141).  Gonadal development during the juvenile period was not 




meiosis is unknown.  The observation that some mlh1-mutant female zebrafish are 
fertile suggests that enough germ cells in the juvenile gonad are able to enter meiosis 
and become perinucleolar oocytes, leading to ovarian differentiation. 
 
A zebrafish line with homozygous mutation of the FA gene fancl was recently 
described.  In this model, homozygous fancl mutation resulted in development of all-
male zebrafish (142).  fancl-mutant zebrafish showed an early bias toward testicular 
differentiation with increased germ cell apoptosis during juvenile gonad development 
(142).  In contrast to brca2
Q658X
 homozygotes, fancl-mutant zebrafish exhibited 
limited early perinucleolar oocyte differentiation, and adult male fancl-mutant 
zebrafish were fertile (142).   These findings further suggest that meiotic progression, 
as well as apoptosis in germ cells, may impact zebrafish gonadal development. 
 
In summary, these studies in zebrafish have demonstrated the following:  1) brca2 is 
not required for embryonic survival; 2) brca2 mutation does not increase embryonic 
sensitivity to ionizing radiation; 3) brca2 mutation results in an all-male phenotype 
characterized by incomplete spermatogenesis, meiotic arrest, and spermatocyte 
apoptosis; and 4) brca2 is essential for ovarian development.  In contrast to mouse 
models, brca2 mutation in zebrafish does not affect embryogenesis, which is likely 
attributable to abundant maternal mRNA for brca2.  However, brca2 is critical for 
meiotic progression in germ cells.  While brca2 plays a conserved role in zebrafish 
spermatogenesis, the importance of brca2 in zebrafish ovarian development is a novel 




Chapter 4:  brca2 in zebrafish gonadogenesis and tumorigenesis 
Introduction 
Establishment of a viable brca2-mutant zebrafish line has revealed that brca2 is 
essential for zebrafish ovarian development.  Evidence from humans and animal 
models with mutations in multiple genes from the Fanconi Anemia family, including 
BRCA2, indicate that this interrelated group of proteins influence gonadal 
morphogenesis (58, 130, 131, 143).  However, the role for BRCA2 in gonadal 
development is poorly defined, and an absolute requirement for BRCA2 in ovarian 
development has not been previously demonstrated.   Further, the link between 
BRCA2 mutation and human ovarian cancer is not understood. 
 
In this chapter, the mechanisms by which brca2 mutation affects zebrafish ovarian 
development are explored.  In addition, the role for brca2 mutation in reproductive 
tumors and the collaborative effects of brca2 mutation and homozygous tp53 
mutation on tumorigenesis are investigated.  These studies indicate that germ cell 
apoptosis in brca2
Q658X
 homozygotes is a critical factor in gonad development.  In 
adulthood, brca2 functions as a tumor suppressor gene in zebrafish.  Adult brca2
Q658X
 
homozygotes develop testicular tumors, and tumorigenesis in multiple tissues is 
accelerated by homozygous tp53 mutation in both brca2
Q658X
 heterozygotes and 






Materials and Methods 
Construction of RNA probes for zebrafish vasa.  A plasmid containing 849 bp of the 
zebrafish vasa cDNA (pExpress-1-vasa; Clone #9787706, Open Biosystems/Thermo 
Scientific, Huntsville, AL) was used to amplify a 549 fragment.  The insert was 
cloned into pCRII-TOPO (Invitrogen) according to the manufacturer’s protocol.  
Cloning reactions were used to transform One-Shot chemically competent E. coli 
(Invitrogen) according to the manufacturer’s protocol.  Preparation of the pCRII-
TOPO-vasa plasmid and transcription of DIG-labeled RNA were performed as 
described in Chapter 2. 
 
Whole-mount in situ hybridization (WISH) for vasa expression in embryos from 
incrosses of brca2
Q658X
 heterozygotes. Embryos from incrosses of brca2
Q658X
 
heterozygous zebrafish were used for analyses of vasa expression at 24 hpf and 4 dpf.  
WISH with antisense and sense probes for vasa on 24 hpf embryos was performed as 
described in Chapter 2.  WISH with antisense and sense probes for vasa on 4 dpf 
larvae was performed as described in Chapter 2 with the following modifications:  1) 
larvae were genotyped before WISH by amputating a portion of the tail for DNA 
extraction and genotyping; 2) larvae were depigmented in 3% H2O2/0.5% KOH as 
described (144); 3) after fixation, larvae were incubated in 0.5 µg/ml  proteinase K 
(Fermentas Inc.) in 1X PBS on ice for ten to fifteen minutes.  Approximately 50 
embryos at 24 hpf were analyzed in three independent experiments and 
approximately 25 – 50 embryos of each genotype were analyzed at 4 dpf in two 




from two independent experiments were individually imaged, and subsequently 
genotyped for the brca2
Q658X
 mutation.  For imaging, embryos were positioned in 
individual wells of a 1% agarose mold and imaged with a Leica MZ16 
stereomicroscope and camera (Leica DFC420) with Leica Imaging Suite.  Embryos 
that were genotyped after WISH were prepared as described (86) with minor 
modifications (volume of DNA extraction buffer increased to 21 µl).   
 
Immunohistochemistry for cleaved caspase-3 in juvenile zebrafish.  Juvenile zebrafish 
from an incross of brca2
Q658X
 heterozygous zebrafish were collected at 28 dpf, 
euthanized, genotyped, and fixed as described in Chapter 3.  After fixation, zebrafish 
were grouped by genotype.  For each specimen, the head, dorsal musculature, and tail 
were removed and the trunk was embedded in agarose molds (2.0% agarose in 
distilled water).  Agarose molds were placed in tissue cassettes for routine processing 
(Histoserv).  Immunohistochemistry for cleaved caspase-3 was performed as 
described in Chapter 3. 
 
Preparation of tdTomato-nos1-3’UTR construct.  A plasmid containing a GFP-nos1-
3’UTR construct (145) (pSP64-GFP-3’UTRnos1) was acquired from the laboratory 
of Dr. Erez Raz (Munster, Germany).  Two new plasmids were constructed: pSP64-
mCherry-3’UTRnos1 and pSP64-tdTomato-3’UTRnos1.  To create pSP64-mCherry-
3’UTRnos1, the pmCherry plasmid (Clontech, Mountain View, CA) was used for 
amplification of an 893 bp fragment of mCherry.  The reverse primer created an XhoI 




at the 5’ end.  The mCherry insert was gel-purified and the pSP64-GFP-3’UTRnos1 
plasmid and insert were digested with BamHI and XhoI.  Purification, ligation, 
transformation, and plasmid preparation of pSP64-mCherry-3’UTRnos1 were 
performed as described in Chapter 2.  To create pSP64-tdTomato-3’UTRnos1, the 
pSP64-mCherry-3’UTRnos1 and the ptdTomato plasmid (Clontech) were digested 
with AgeI and XhoI.  Purification, ligation, transformation, and plasmid preparation of 
pSP64-tdTomato-3’UTRnos1 were performed as described in Chapter 2.  Preparation 
of tdTomato-3’UTRnos1 capped mRNA was performed with a commercially 
available kit according to the manufacturer’s protocol (mMESSAGE mMACHINE 
Kit; Applied Biosystems/Ambion, Austin, TX). 
 
Preparation of donor embryos for primordial germ cell transplants.  
tg(bactin2:EGFP)zp5 zebrafish embryos were acquired from Zebrafish International 
Resource Center (ZIRC).  Adult tg(bactin2:EGFP)zp5 were incrossed and embryos 
collected from these crosses were used as donor embryos.  At the one- to two-cell 
stage, donor embryos were injected with tdTomato-nos1-3’UTR RNA (300 
pg/injection) and Oregon Green dextran conjugate (Invitrogen; 5 ng/injection) in 
0.1M KCl using a microinjector (Harvard Instruments, PLI-100).  After injection, 
donor embryos were incubated at 26 – 28°C.  At approximately 2 hpf, donor embryos 
were dechorinated with 0.05% Pronase (Sigma), rinsed in system water, and collected 
into glass or agarose-coated plastic plates containing 30% Danieau’s medium and 200 





Preparation of recipient embryos for primordial germ cell transplants.  Embryos 
were collected from incrosses of brca2
Q658X
 heterozygous zebrafish.  At the one-cell 
stage, embryos were injected with 1 ng of dead-end morpholino (dnd MO) (84) in 1X 
Danieau’s medium and 0.025% Phenol Red using a microinjector (World Precision 
Instruments, PV-820).  After injection, embryos were incubated at 26 – 28°C.  At 
approximately 2 hpf, embryos were dechorinated with 0.05% Pronase (Sigma), rinsed 
in system water, and collected into glass or agarose-coated plastic plates containing 
30% Danieau’s medium and 200 µg/ml Penicillin-Streptomycin (Gibco). 
 
Primordial germ cell transplant into embryos collected from incrosses of brca2
Q658X
 
heterozygotes.  At approximately 2.5 hpf, donor and recipient embryos were placed in 
agarose ramps in 30% Danieau’s medium and 200 µg/ml Penicillin-Streptomycin 
(Gibco).  Cells were collected from the margins of donor embryos with pulled glass 
capillary needles that were attached by flexible tubing to a 10-ml syringe.  Donor 
cells were transplanted into the animal pole of recipient embryos.  After transplant, 
recipient embryos were placed on glass or agarose-coated plastic plates in 1X 
Danieau’s medium and 200 µg/ml penicillin-streptomycin and incubated at 26 – 
28°C.  Transplanted embryos were screened at 24 or 48 hpf for the presence of cells 
expressing GFP/Oregon Green and/or tdTomato in the region of the gonadal ridge. 
 
Analyses of adult chimeric zebrafish.  Chimeric zebrafish were raised to adulthood, 
genotyped for the brca2
Q658X 
mutation, and sexed by phenotypic features.  Each 




Approximately 100 eggs collected from each of these crosses were screened by 
microscopy.  Chimeric zebrafish which did not generate fertilized eggs in these 
crosses were considered sterile.  Chimeric zebrafish which generated fertilized eggs 
in these crosses were considered fertile.  Viable embryos from chimeric-wildtype 
zebrafish crosses were incubated at 26 – 28°C and screened daily for mortality and 
morphologic development.  At 3 – 5 dpf, between 16 – 40 embryos from each 
breeding pair were individually digested in 30 – 50 µl DNA lysis buffer with 0.2 
mg/ml Proteinase K (Fermentas Inc.) for DNA extraction.  Individual embryos were 
genotyped for the brca2
Q658X 
mutation as described in Chapter 3.  Individual embryos 
were also genotyped for the (bactin2:EGFP)zp5 transgene according to the protocol 
provided by the supplier. 
 
Histologic analyses of tumorigenesis in zebrafish testes.  Aged adult wildtype, 
brca2
Q658X
 heterozygous, and brca2
Q658X
 homozygous male zebrafish were 
euthanized between the ages of 10 and 16 months.  The testes were dissected, 
grouped by genotype, and fixed as described in Chapter 3, and placed in tissue 




 mutation. Zebrafish embryos homozygous for the tp53
M214K
 
mutation were acquired from ZIRC.  Adult tp53
M214K 
homozygous zebrafish were 
crossed with brca2
Q658X
















 mutation as described or by sequencing.  Progeny were also genotyped for 
the tp53
M214K
 mutation either by following the protocol provided by the supplier or by 
DNA sequencing. 
 
Analyses of tumorigenesis in adult zebrafish. Adult zebrafish were regularly 
monitored for evidence of morbidity or overt tumor development.  Tumor 
development in the tp53
M214K
 homozygous parental line was defined by gross 
observation of macroscopically identifiable tumors in live or euthanized zebrafish as 
described (70).  A subset of tp53
M214K
 homozygous zebrafish was additionally 





 heterozygous zebrafish were evaluated for macroscopic 
tumor development and by histology.  The ages at tumor onset in each genotype of 
zebrafish were compared by unpaired t-tests. 
 
Results 
Germ cell designation and colonization of the genital ridge and germ cell survival in 
brca2
Q658X
-mutant zebrafish.   
Development of all-male populations has been described in zebrafish with embryonic 
loss of primordial germ cells (PGCs) or failure of PGCs to migrate to the embryonic 
gonadal ridge (84, 85). Therefore, we evaluated embryos from incrosses of 
brca2
Q658X
 heterozygous zebrafish for the presence and appropriate localization of 
PGCs at 24 hpf and 4 dpf by WISH for the germ cell marker vasa (Fig. 4.1A).  Vasa 





Fig. 4.1 Germ cell specification and survival in brca2
Q658X
 homozygotes.  (A) 
WISH with antisense (AS) and sense (S) RNA probes for vasa indicates appropriate 





 homozygous embryos.  (B) Immunohistochemistry for 
cleaved caspase-3 in juvenile gonads from wildtype and brca2
Q658X
 homozygotes.  
Multiple apoptotic cells are present in gonads from juvenile brca2
Q658X
 homozygotes.  
(C) Homozygous tp53
M214K
 mutation rescues ovarian development in brca2
Q658X
 




 homozygous zebrafish 
develop binucleate oocytes (inset).  CC3, anti-cleaved caspase-3; neg, negative 





localization in wildtype, brca2
Q658X
 heterozygotes, or brca2
Q658X
 homozygotes (Fig. 




 mutation did not appear to affect embryonic PGC designation, 
germ cell survival was impaired in juvenile gonads from brca2-mutant zebrafish.  
Immunohistochemistry for cleaved caspase-3 on gonads from brca2
Q658X
 
homozygotes at 28 dpf demonstrated multiple apoptotic cells (Fig. 4.1B).  In contrast, 
apoptotic cells were rare in gonads from wildtype zebrafish at 28 dpf (Fig. 4.1B). 
 
Homozygous tp53 mutation rescues ovarian development in brca2
Q658X
-mutant 
zebrafish.   
To determine how germ cell apoptosis might impact gonad development in brca2-
mutant zebrafish, brca2
Q658X







 heterozygous zebrafish were subsequently 
incrossed, and progeny were raised to adulthood.  
 





 homozygous zebrafish that died or were euthanized due to 
tumor development revealed that two zebrafish had developed ovaries (Fig. 4.1C).  





homozygous zebrafish.  However, the ovaries contained multiple binucleate oocytes 





 homozygous or tp53
M214K









 homozygous zebrafish 
were outcrossed to fertile wildtype female zebrafish, but eggs collected from these 





 homozygous zebrafish were unsuccessful. 
 
PGC transplant rescues fertility in brca2
Q658X
-mutant zebrafish.    
To determine whether brca2-mutant stromal cells impact gonad development, PGCs 
were transplanted into embryos from incrosses of brca2
Q658X
 heterozygous zebrafish 
(Fig. 4.2).  The endogenous PGCs in transplanted embryos were ablated via injection 
with dnd MO (84) prior to transplant.  To confirm successful PGC ablation in 
recipient embryos, a subset of embryos were screened by WISH for vasa after 
injection with dnd MO (Appendix XI).  PGCs were collected from 
tg(bactin2:EGFP)zp5 zebrafish, which express EGFP under the control of the β-actin 
promoter (146).  To maximize visibility of transplanted cells, donor embryos were 
injected with Oregon Green dextran conjugate (labeling all cells) and tdTomato-nos1-
3’UTR RNA (labeling PGCs) (Fig. 4.3A).   
 
Transplanted embryos were screened at 24 or 48 hpf for the presence of donor cells.  
Since the tdTomato-nos1-3’UTR RNA construct was not consistently detectable in 
donor embryos or transplanted embryos, embryos were screened for Oregon Green-





Fig. 4.2 Primordial germ cell transplant method.  Donor embryos are collected 
from incrosses of tg(bactin2:EGFP)zp5 zebrafish and coinjected at the 1-cell stage 
with tdTomato-nos1-3’UTR RNA and Oregon Green dextran conjugate.  Recipient 
embryos are collected from incrosses of brca2
Q658X
 heterozygous zebrafish and 
injected at the 1-cell stage with dnd MO.  When donor and recipient embryos have 
reached mid-blastula stage (2.5 – 3 hpf), donor cells are collected from the margin 
zone and injected into the animal pole of recipient embryos.  Transplanted embryos 
are screened at 24 or 48 hpf for localization of transplanted germ cells to the 
embryonic genital ridge.  Transplanted somatic cells do not migrate from the animal 





Fig. 4.3 Primordial germ cell transplantation and screening of chimeric 
embryos.  (A) Donor embryos are injected with Oregon Green dextran (OG), labeling 
all cells, and tdTomato-nos1-3’UTR RNA, labeling primordial germ cells (white 
arrows).  (B) Chimeric embryo with OG-positive primordial germ cells localized at 
the genital ridge (white arrow) and OG-positive somatic cells in the head and eye.  
(C) Chimeric embryo with OG-positive somatic cells only in the head and eye.  (D)  
Genotyping for the bactin2:EGFP transgene in embryos from a cross of an adult 
chimeric brca2
Q658X
 homozygote and fertile wildtype female zebrafish shows that 
germ cells are derived from tg(bactin2:EGFP)zp5 donors.  Redundant controls have 
been removed from the gel image (white line).  (E) Genotyping for the brca2
Q658X 
mutation in embryos from a cross of an adult chimeric brca2
Q658X
 homozygote and 
fertile wildtype female zebrafish shows that germ cells do not carry the brca2
Q658X
 
mutation.  Chim, embryo DNA from chimeric zebrafish-wildtype cross; BA-GFP, 
tg(bactin2:EGFP)zp5 embryo DNA; AB*, embryo DNA from wildtype AB* 
zebrafish; Positive, DNA from a brca2
Q658X




transplants were performed into the animal pole, somatic cells did not migrate, and 
remained in cephalic tissues in transplanted embryos (Fig. 4.3B, C). 
 
Chimeric embryos were raised to adulthood and genotyped for the brca2
Q658X
 
mutation.  Chimeric brca2
Q658X
 heterozygotes (n = 12) and homozygotes (n = 8) were 
crossed to fertile wildtype AB* zebrafish to screen for fertility, and embryos were 
collected for analysis (Table 4.1).  Chimeric wildtype zebrafish were not screened for 
fertility (n = 11).  Fertile chimeras included one male brca2
Q658X
 homozygote, two 
male brca2
Q658X
 heterozygotes, and two female brca2
Q658X
 heterozygotes (Table 4.1).  
Embryos from crosses of chimeric and wildtype zebrafish carried the bactin2:EGFP 
transgene (Fig. 4.3D) and were wildtype for brca2 (Fig. 4.3E).  These data indicate 
successful ablation of endogenous germ cells and replacement with germ cells from 
tg(bactin2:EGFP)zp5 donors in chimeric zebrafish.  While PGC transplantation 
rescued fertility in one brca2
Q658X




-mutant zebrafish are predisposed to testicular neoplasia.   
Since BRCA2 mutations in humans are predominantly associated with cancer 
development in reproductive tissues, the testes from aged adult brca2
Q658X
 
homozygotes were screened histologically for tumor development.  Between ten and 
sixteen months of age, four out of thirteen (31%) of brca2
Q658X
 homozygotes 
developed testicular neoplasia (Fig. 4.4).  Testicular tumors were of both somatic cell 
and germ cell origin and included undifferentiated stromal cell tumor (Fig. 4.4A, B), 




 Adult chimera genotype and phenotype Embryo genotype 
Specimen brca2
Q658X
 genotype Sex Fertile/Sterile tg(bactin2:EGFP)zp5 brca2
Q658X
  
1 +/- M F Y +/+ 
2 +/- F F  Y* +/+ 
3 +/- F F Y +/+ 
4 +/- M F Y +/+ 
5 +/- M S   
6 +/- M S   
7 +/- M S   
8 +/- M S   
9 +/- M S   
10 +/- M S   
11 +/- M S   
12 +/- M S   
  13 -/- M F Y +/+ 
14 -/- M S   
15 -/- M S   
16 -/- M S   
17 -/- M S   
18 -/- M S   
19 -/- M S   
20 -/- M S   
 
Table 4.1 Genotype and phenotype of chimeric brca2
Q658X
-mutant zebrafish.  
Adult chimeric zebrafish were genotyped and subsequently outcrossed to fertile 
wildtype AB* zebrafish.  Fertilized embryos collected from these crosses were 
genotyped for the bactin2:EGFP)zp5 transgene and for the brca2
Q658X 
mutation to 
confirm ablation of endogenous PGCs and successful PGC transplant. 
 
*The majority of embryos from this specimen were negative for the 
bactin2:EGFP)zp5 transgene (40 embryos were genotyped individually from this 
cross).  After beginning PGC transplants, it was found that small numbers of embryos 
from incrosses of tg(bactin2:EGFP)zp5 zebrafish did not carry the 
(bactin2:EGFP)zp5 transgene.  In specimen 3, it is presumed that most of the 
transplanted donor PGCs did not carry the (bactin2:EGFP)zp5 transgene.  However, 
the endogenous germ cells for this specimen were successfully ablated, since all 










 homozygotes are predisposed to testicular neoplasias.  (A) 
Undifferentiated stromal cell tumor from a brca2
Q658X
 homozygote.  Neoplastic 
spindle cells form irregular bundles (inset).  (B) Undifferentiated stromal cell tumor 
from a brca2
Q658X
 homozygote.  Neoplastic spindle cells form irregular bundles 
around poorly defined tubular structures (inset).  (C) Papillary cystadenoma from a 
brca2
Q658X
 homozygote.  Neoplastic cells form papillary projections and are often 
vacuolated (inset).  (D) Seminoma from a brca2
Q658X
 homozygote.  Neoplastic cells 
have a high nuclear:cytoplasmic ratio and prominent nuclei and nucleoli (inset).  




testes from aged adult brca2
Q658X
 homozygotes included germ cell hyperplasia and 
dysplasia and segmental testicular degeneration (Appendix XII). 
 
In contrast, no testicular tumors were observed in age-matched cohorts of wildtype (n 
= 12) and brca2
Q658X
 heterozygotes (n = 12).  Hyperplastic, dysplastic, and 
degenerative changes observed in testes from brca2
Q658X
 homozygotes were not seen 




Collaborative effects of tp53 and brca2 mutations on tumorigenesis.   





 heterozygous zebrafish revealed that combined mutations in 
brca2 and tp53 accelerated the onset of tumor development (Fig. 4.5A and Table 4.2).  









homozygous zebrafish when compared to the tp53M214K homozygous parent line 










 homozygous zebrafish, and the ages at tumor onset were similar 
to those observed in the tp53M214K homozygous parent line (Table 4.3). 
 









 homozygous zebrafish 









homozygous zebrafish.  (A) Age at tumor onset is 









 homozygous zebrafish compared to the 
tp53
M214K
 homozygous zebrafish parent line.  (B) The ovary is a primary site for 




 homozygous zebrafish, 
with oocyte entrapment (inset).  OC, oocyte; CR, cranial; D, dorsal; V, ventral; SB, 













 -/-  tp53
 M214K 
-/-  



















































Total 8 9 32 









 -/-   
tp53
 M214K 







p = 0.5643   
 
Table 4.2 Analysis of ages at tumor onset in brca2
Q658X
-mutant zebrafish with 









 homozygous zebrafish compared to the parent line of 
tp53
M214K
 homozygous zebrafish.  Data sets were compared by unpaired t-tests 










Specimen Age (mo) Sex Diagnosis Primary site(s) 






2 7.0 F 1) MPNST 1) Ovary 




4* 8.0 ND 1) Eye mass with proptosis 1) Eye 
5 9.0 M 1) MPNST 1) Coelom 
6 9.5 ND 1) MPNST 
2) MPNST 
3) Cutaneous hemangiosarcoma 
1) Coelom 
2) Subpharyngeal  
3) Tail 
7 11.0 M 1) Seminoma 1) Testis 
8 11.0 F 1) Rhabdomyosarcoma 1) Head 
 brca2Q658X +/-; tp53M214K -/- 
Specimen Age (mo) Sex Diagnosis Primary site(s) 
9 6.5 F 1) MPNST 1) Coelom 
10 8.0 F 1) MPNST 1) Ovary 
11 8.0 F 1) MPNST 1) Ovary 




13 8.5 M 1) Sarcoma 1) Coelom 
14 10.0 F 1) Sarcoma 1) Ovary 




16 11.0 F 1) MPNST 1) Coelom 
17 11.0 F 1) Intestinal adenocarcinoma 
2) Cutaneous hemangioma 
1) Intestine 
2) Body wall 
 brca2Q658X +/+; tp53M214K -/- 
Specimen Age (mo) Sex Diagnosis Primary site(s) 
18 10.0 F 1) Primitive neuroectodermal tumor 1) Coelom 
19 11.0 F 1) MPNST 1) Body wall 
  tp53M214K -/- parent line 
Specimen Age (mo) Sex Diagnosis Primary site(s) 
20 7.0 F 1) MPNST 1) Liver 
21 10.0 F 1) MPNST 1) Caudal coelom/ovary 
22 11.0 F 1) MPNST 1) Caudal coelom/ovary 
23 11.5 M 1) Rhabdomyosarcoma 1) Tail 
24 11.5 F 1) MPNST 1) Coelom 





Table 4.3 Histologic analyses of tumor types and primary sites of development in 
brca2
Q658X
-mutant zebrafish with concomitant tp53 mutation. Tumors in zebrafish 




 heterozygous zebrafish and in a 
subset of zebrafish from the parent line of tp53
M214K
 homozygous zebrafish were 
evaluated histologically.  MPNST, malignant peripheral nerve sheath tumor; ND, not 








 homozygous zebrafish, 
the ovaries appeared to be the primary site for tumor development (Fig. 4.5B).  





female zebrafish also appeared to primarily involve the ovary (Table 4.3).  Primary 
tumorigenesis in the gonads was not typical of a subset of tp53
M214K
 homozygous 
zebrafish evaluated histologically (Table 4.3), and was not reported in 
characterization of the tp53
M214K
 zebrafish line (70).   
 
While malignant peripheral nerve sheath tumors predominated, a variety of other 









 homozygous zebrafish 
(Fig. 4.6).  Frequently, one or more zebrafish developed tumors in more than one 








-mutant zebrafish with concomitant homozygous tp53 
mutation develop a variety of solid tumors.  (A) Intraocular malignant peripheral 









 homozygous zebrafish.  (C) Intramuscular 




 homozygous zebrafish.  (D) 




 homozygous zebrafish 
with characteristic strap cells (inset, arrow).  BR, brain; ON, optic nerve; IN, 






Investigation of the brca2
Q658X 
mutation in zebrafish revealed that brca2 is 
dispensable for embryonic survival, but is critical for spermatogenesis and ovarian 
development.  Since BRCA2 is known to be required in germ cells for meiotic 
recombination, meiotic failure in adult male brca2
Q658X 
homozygous testes 
demonstrates a conserved role for brca2 in germ cell maturation.  However, little is 
known about the participation of BRCA2 in primordial germ cell-stromal cell 
interactions in the immature gonad.  Thorough studies of gonadal morphogenesis are 
limited in Brca2-mutant mouse models (58), as well as in patients with BRCA2 
mutations (130).  Thus, the brca2
Q658X
-mutant zebrafish line provides a unique 
opportunity for investigating the effects of brca2 mutation on gonad development. 
 
Previous studies in zebrafish indicate that primordial germ cells (PGCs) are required 
for ovarian development in zebrafish.  All-male populations of zebrafish develop 
when PGCs fail to migrate to the embryonic genital ridge (83, 84).  Furthermore, 
germ cell depletion by gene mutation or knockdown generates predominantly male 
zebrafish populations with structurally and functionally male gonads (84, 85).  
However, WISH for the germ cell marker vasa indicated that PGC designation and 
colonization of the genital ridge were unimpaired in brca2-mutant zebrafish embryos.  
Therefore, failure of ovarian development in brca2
Q658X
 homozygotes suggests a 





Immunohistochemistry for cleaved caspase-3 in juvenile brca2-mutant zebrafish at 30 
days of age demonstrated multiple apoptotic cells in gonads from brca2
Q658X
 
homozygotes.  Furthermore, homozygous tp53 mutation rescued ovarian development 
in a small number of brca2
Q658X
 homozygotes.  Together these data indicate that germ 
cell apoptosis is an important contributor to the failure of ovarian development 
observed in brca2
Q658X
 homozygotes.  Apoptosis of perinucleolar oocytes is a normal 
occurrence during the transformation from juvenile ovaries to testes in male zebrafish 
(80).   Numerous apoptotic cells may be observed in gonads of presumptive males, in 
contrast to presumptive females (80).  This suggests that apoptotic loss of germ cells 
in the developing gonad may be an important signal for directing testicular 
differentiation in zebrafish.   
 
As discussed in Chapter 3, meiotic arrest and subsequent germ cell degeneration is 
not associated with lack of ovarian development in mammalian species.  However, 
some studies in mammalian species suggest that embryonic germ cells may play a 
role in maintaining the ovarian phenotype.  Various animal models for ovarian sex 
reversal have demonstrated development of Sertoli-like cells and seminiferous-like 
cords in embryonic mammalian ovaries (147).  Under these circumstances, 
development of male stromal elements was preceded by extensive germ cell loss 
(147).  Thus, while the effects of germ cell depletion on zebrafish ovarian 
development are relatively more profound, germ cell survival in mammalian 





To investigate the role for primordial germ cells in gonad development in brca2
Q658X
 
homozygotes, PGC transplant experiments were performed to replace endogenous, 
brca2-mutant germ cells with meiotically competent germ cells.  PGC transplantation 
into embryos from incrosses of brca2
Q658X
 heterozygotes resulted in low numbers of 
fertile adult zebrafish.  The use of tg(bactin2:EGFP)zp5 embryos as donors was 
important in confirming that endogenous germ cells had been ablated and replaced by 
donor germ cells.  While transplantation of meiotically competent PGCs rescued 
fertility in brca2
Q658X
 homozygotes, female chimeric brca2
Q658X
 homozygotes have 
yet to be recovered from these experiments.  Previous studies of PGC transplantation 
in zebrafish have demonstrated that male populations of chimeric zebrafish are 
generated when single PGCs are transplanted to recipient embryos (148).  As ovarian 
development in brca2
Q658X
 homozygotes was rescued by homozygous tp53 mutation, 
failure to rescue ovarian development by germ cell transplantation may indicate that 
few PGCs were transplanted in initial transplant experiments. 
 




 homozygous ovaries.  A role for BRCA2 in cytokinesis has 
been previously suggested, with BRCA2 knockdown or loss resulting in incomplete 
cell division (149).  Aberrant or delayed cytokinesis has been described in embryonic 
fibroblasts derived from Brca2-deficient mice as well as in primary fibroblast cultures 
collected from human carriers of BRCA2 mutations (149, 150).  Failure of cytokinesis 
was not reported in cultured BRCA2-deficient cells (149, 150), in contrast to the 








homozygous ovaries.  While the effects of BRCA2 on cytokinesis remain 
controversial (151), the findings reported herein suggest an association between 
BRCA2 mutation and aberrant cytokinesis. 
 
The impact of BRCA2 mutation on cancer susceptibility, particularly in reproductive 
tissues, is also conserved in zebrafish.  In wildtype populations, aged male zebrafish 
demonstrate a relatively high frequency of seminomas (152, 153).  Additionally, a 
high incidence of germ cell tumors has been reported in the lamc1
cz61
-mutant 
zebrafish line, although the mutant locus associated with tumorigenesis was not 
identified (154).  Adult brca2
Q658X
 homozygotes exhibited a propensity for testicular 
tumors that was not observed in age-matched siblings.  Unlike previous reports of 
testicular tumorigenesis in zebrafish, brca2
Q658X
 homozygotes developed testicular 
tumors that were predominantly of somatic cell origin.  In comparison, ovarian 
cancers in women with BRCA2 mutations also arise from somatic cell populations (8-
11).  Thus, these findings in brca2
Q658X
 homozygotes demonstrate a conserved and 
primary role for BRCA2 mutation in tumorigenesis of reproductive tissues. 
 
Tumorigenesis in mice with hypomorphic or C-terminal mutations in Brca2 has 
infrequently involved reproductive tissues.  The most common tumors described in 
viable Brca2-mutant mice are lymphomas and carcinomas of the gastrointestinal tract 
(52, 54-56).  A spectrum of tumor types was also reported in a Brca2-mutant rat 
model, although female Brca2-mutant rats did develop ovarian tumors (59).  The 




susceptibility, methods used to generate BRCA2 mutation, and/or variability in the 




 mutation accelerated tumorigenesis in multiple 
tissues in both brca2
Q658X
 heterozygotes and brca2
Q658X
 homozygotes.  The majority 
of zebrafish developed malignant peripheral nerve sheath tumors, similar to those 
described previously in tp53
M214K









homozygous zebrafish exhibited a tendency for primary tumor development in the 
ovary, which was not typical of female zebrafish with homozygous tp53
M214K
 
mutation alone (70).  These observations, while limited in number, suggest a specific 
role for brca2 mutation in gonad tumorigenesis, and imply collaborative effects of 
tp53 and brca2 mutations on tumorigenesis.  Interestingly, combined mutations in 
Brca2 and Tp53 in mouse models have also been shown to reduce survival and 
increase tumor incidence (51, 57). 
 
In humans, somatic mutations in p53 are one of the most common genetic aberrations 
observed in ovarian cancer cells (19, 20).  Recent studies have identified a so-called 
“p53 signature” lesion, referring to expression of p53 in morphologically normal 
epithelia, as an indication of p53 mutation and an important precursor to malignant 
transformation (155).  The p53 signature has been described with similar frequency in 
ovarian and tubular tissues from women with and without mutations in the BRCA 




BRCA-associated ovarian cancers (157).  A recent model for the development of 
BRCA-associated ovarian cancer suggests that p53 mutation in serosal or fimbrial 
epithelial cells occurs early in neoplastic transformation, and overt carcinogenesis is 
preceded by loss of heterozygosity for BRCA1 or BRCA2 (20).  These studies thus 
indicate that p53 mutation is an important event in BRCA2-associated carcinogenesis, 
similar to what has been observed in brca2-mutant zebrafish. 
 
Several in vitro studies indicate that p53 physically interacts with multiple proteins 
involved in homologous and meiotic recombination, including RAD51, DMC1 and 
BRCA2 (158, 159).  These interactions point to a mechanism for cell cycle control, 
perhaps providing the opportunity to detect abnormal synapses or recombinatorial 
events (158, 159).   These findings suggest that aberrant or incomplete DNA repair 
occurring in mitosis or meiosis in BRCA2-deficient cells may persist with concurrent 
p53 mutation, supporting the concept that mutations in p53 and BRCA2 act 
synergistically during carcinogenesis. 
 
In summary, these studies demonstrate that tp53-mediated germ cell apoptosis plays a 
significant role in gonad development in brca2-mutant zebrafish.  Meiotic failure in 
germ cells acts may act as an additional influence in this process.  The role for brca2 
in cytokinesis is unclear; however, this model provides a unique opportunity to 
further explore this issue.  Importantly, these studies indicate a conserved role for 
brca2 in tumors of reproductive tissues, and support the concept that tp53 mutation is 




Chapter 5: Conclusion and Discussion 
 
Known risk factors for human ovarian cancer are few, and some risk factors, such as 
aging and reproductive history, are nonspecific or poorly understood (3, 4).  A family 
history of breast or ovarian cancer remains the most well-defined predictor of ovarian 
cancer risk (18).   The majority of these hereditary cases are associated with 
mutations in a small number of genes, which includes BRCA2 (12, 15, 18).  While 
mutations in BRCA2 clearly confer an increased risk for ovarian cancer (28), the 
mechanistic link between BRCA2 mutation and these tumors is not understood.   
 
BRCA2 is required for homologous recombination following double-strand DNA 
breaks (31).  In somatic cells, this process is necessary for optimal error-free repair 
after DNA damage occurs (30-32).  Thus, the pathogenesis of BRCA2-associated 
carcinogenesis is thought to involve progressive accumulation of unrepaired or 
misrepaired DNA (30-32).  In vitro data support this concept; BRCA2-deficient cell 
lines exhibit many genetic aberrations that are indicative of defects in DNA repair 
(32, 37).  In vivo data from traditional murine models has been limited by early 
embryonic lethality in Brca2 homozygous mutants in many studies (see Chapter 1, 
Table 1.2).  Individual reports describing viable Brca2-mutant mice and rats have 
confirmed that mutations in Brca2 are associated with increased cancer susceptibility 
(51, 55, 56, 59, 60).  However, these studies have failed to further define the specific 





We developed the zebrafish as a novel model for studying brca2 mutation in vivo.  
These studies were designed to investigate the effects of brca2 mutation on 
embryogenesis, development, gonadal pathophysiology, and cancer susceptibility in 
zebrafish.  The brca2-mutant zebrafish line described herein (brca2
Q658X
) was derived 
from an ENU-mutagenized library, and carries a nonsense mutation in brca2 exon 11.  
This mutation is similar in location and type to deleterious BRCA2 mutations in 
women with hereditary breast and/or ovarian cancer (17).  In preparation for studies 
of brca2
Q658X
-mutant zebrafish, brca2 expression during embryogenesis in wildtype 
AB* zebrafish was examined.  Histologic, immunohistochemical, and in situ 
hybridization studies of juvenile gonads, ovaries, and testes from wildtype AB* 





Since Brca2 mutation profoundly affects embryonic development and survival in 
mouse models, we examined the expression of brca2 throughout embryogenesis.  The 
pattern of brca2 expression in zebrafish embryos was similar to that observed in 
mouse embryos (115-117), suggesting that brca2 may play a conserved role during 
embryogenesis in animal species.  However, the source of this RNA (maternal or 
zygotic) during embryogenesis may be a critical difference in these species.  
Zebrafish embryos, which rely on maternal RNA until approximately the 1000 cell 
stage (119), have high levels of brca2 RNA throughout embryogenesis.  This 
indicates that abundant maternally provided brca2 RNA is available from the earliest 




begins at the one or two-cell stage (120, 121).  Because zebrafish embryos can rely on 
maternal RNA until a later developmental stage, the effects of BRCA2 mutation may 




-mutant zebrafish embryos indicate that maternal RNA for 
brca2 may indeed be protective.  No developmental phenotype was observed in 
association with heterozygous or homozygous brca2
Q658X 
mutation in zebrafish 
embryos.  However, embryonic viability in brca2
Q658X
-mutant zebrafish could also 
indicate reliance on other DNA repair mechanisms.  Zebrafish embryos are capable of 
highly efficient and accurate DNA repair by processes other than homologous 
recombination (160).  Thus, survival of brca2-deficient zebrafish embryos may be 
attributable to this characteristic as well. 
 
Analyses of juvenile and adult brca2
Q658X
 homozygotes indicate that brca2 is 
required for ovarian development in zebrafish.  Adult brca2
Q658X
 homozygotes were 
all male, and exhibited aberrant spermatogenesis and testicular hypoplasia 
characterized by meiotic arrest and clonal apoptosis of spermatocytes.  Histologic 
examination of germ cell morphology in brca2
Q658X
 homozygous testes showed that 
spermatogenesis was arrested after formation of primary spermatocytes.  Primary 
spermatocytes enter and complete meiosis I during spermatogenesis (75, 76); thus, 
meiotic arrest at this stage in brca2
Q658X
 homozygotes is compatible with the known 
role for brca2 in meiotic prophase I.  These findings demonstrate that the requirement 





Studies of juvenile brca2
Q658X
 homozygotes showed that brca2 mutation prevents 
oocyte development during gonadogenesis, a process that normally occurs in all 
zebrafish during the juvenile period (77, 79).  In addition, brca2
Q658X
 homozygous 
mutation is associated with increased germ cell apoptosis in juvenile gonads.  These 
studies suggest two potential mechanisms for failure of ovarian development in 
brca2
Q658X
 homozygotes:  1) failure for germ cells to enter meiosis and form 
perinucleolar oocytes in the juvenile gonads; and 2) extensive germ cell apoptosis in 
the juvenile gonads.  Both hypotheses imply that alterations in germ cell function or 
survival critically impact gonad development in zebrafish. 
 
Evidence from animal models indicates that the onset of meiosis in embryonic germ 
cells is a function of somatic cell-germ cell signaling.  Early studies of embryonic 
gonad development demonstrated that female germ cells cultured with embryonic 
male genital ridges fail to begin meiosis (132).  In contrast, male germ cell cultured 
with female embryonic genital ridges enter meiotic prophase (132).  More recent 
studies have defined some of the signaling pathways that initiate or repress meiosis in 
germ cells.  In mouse embryos, signaling for meiotic initiation in germ cells begins 
with the production of retinoic acid (RA) from the embryonic mesonephros (134, 161, 
162).  Expression of genes responsive to RA signaling in female germ cells, including 
Stra8 and Dazl, is required for meiotic initiation (134, 135).  In male embryos, 
gonadal somatic cells express the RA-metabolizing enzyme Cyp26b1, thus preventing 




that do not express Stra8 or Dazl do not enter meiosis (134, 135).  These studies 
indicate that successful meiotic initiation in female gonads requires two elements:  
appropriate signaling from the mesonephros and gonadal stroma, and germ cells that 
can respond to these signals and enter meiosis. 
 
As discussed in Chapter 3, gonad differentiation along male or female lines in 
mammalian species is generally dictated by chromosomal sex (94), and is not 
changed by meiotic failure in embryonic germ cells (58, 131, 136, 137).  In contrast, 
germ cells have a significant role in directing male or female gonad development in 
zebrafish (83, 84, 90).  If germ cells cannot initiate meiosis during zebrafish gonad 
development, this could alter somatic cell-germ cell signaling that would otherwise 
lead to ovarian differentiation.  Germ cells in juvenile gonads from brca2
Q658X
 
homozygotes are likely to be meiotically incompetent.  Early meiotic and 
perinucleolar oocytes express brca2 in wildtype juvenile zebrafish gonads.  Since 
these cell types are not found in brca2
Q658X 
homozygotes, this implies a requirement 
for brca2 in meiotic initiation and development of these cell populations.  As stra8 
and dazl have not been described in zebrafish gonad development, their roles in these 
processes are unknown.  However, the association between meiotic arrest in germ 
cells and testicular development in brca2
Q658X
 homozygotes suggests that meiotic 
initiation in germ cells is critical for ovarian development in zebrafish.   
 
The second potential mechanism for failure of ovarian development involves 




germ cell loss in mammalian embryonic gonads can lead to formation of 
seminiferous-like cords in females (147).  Similarly, germ cell depletion during 
embryogenesis results in testicular differentiation in zebrafish (83-85).  In our studies, 
homozygous tp53 mutation rescued ovarian development in brca2
Q658X
 homozygotes.  
These data show that germ cell apoptosis is a key element for failure of ovarian 
development in brca2
Q658X
 homozygotes.  Interestingly, studies of germ cell depletion 
in mammalian embryonic gonads indicate that loss of germ cells in female gonads at 
the meiotic stage, rather than the mitotic stage, can lead to transdifferentiation of 
granulosa cells and formation of seminiferous-like cords (147).  Furthermore, studies 
in mouse models with germ cell loss during development suggest that germ cells are 
dispensable for testicular morphologic integrity in mammals (138).  Therefore, it is 
possible that both meiotic failure and germ cell apoptosis work in combination to 
direct testicular development in brca2
Q658X
 homozygous zebrafish. 
 
In addition to determining a novel role for brca2 in zebrafish ovarian development, 
these studies demonstrate that the association between brca2 mutation and 
tumorigenesis in reproductive tissues is conserved in zebrafish.  Importantly, the 
majority of these tumors originated from somatic cell populations in the adult 
zebrafish testes.  Similarly, ovarian carcinomas in women arise from epithelia of the 
ovarian surface or tubules (8-11), i.e. somatic cell populations, rather than germ cells.  





 heterozygotes, and these mutations were associated with 




p53 and BRCA2 are also important factors in human ovarian carcinogenesis (19, 20).  
These findings in brca2
Q658X
-mutant zebrafish are in contrast to tumor susceptibilities 
in viable Brca2-mutant rodent models, which are reported to develop a wide variety 
of tumor types (51, 55, 56, 59, 60).  This variation among species may reflect 
differences in cancer susceptibility, methods used for generating BRCA2 mutations, 
and/or variability in the location of the BRCA2 mutation in these models. 
 
The studies of brca2
Q658X
-mutant zebrafish reported herein suggest a novel approach 
in considering the link between BRCA2 mutation and human ovarian cancer.  As 
discussed previously, BRCA2 mutation in the ovarian surface epithelium or fimbria, 
followed by the accumulation of subsequent genetic changes, is thought to lead to 
neoplastic transformation (20).  It is also possible that BRCA2 mutation in germ cells 
adversely affects ovarian physiology, as was observed during gonad development in 
brca2
Q658X
-mutant zebrafish.  If so, altered intercellular signaling among germ cell 
and stromal cell populations might contribute to cellular transformation.  In 
mammals, germ cells appear to play a significant role in both ovarian development 
and maintenance of the ovarian phenotype (147).  The role for BRCA2 in ovarian 
development and the effects of BRCA2 mutation on intercellular signaling in the 
gonad are not known.  Thus, the implications of these studies for BRCA2-associated 
ovarian cancer are as yet unclear.  However, studying the effects of brca2 mutation 
on gonad development and tumorigenesis in zebrafish has provided new insight into 





In summary, these studies have generated a novel zebrafish model for studying brca2 
mutation in vivo; established a conserved role for brca2 in zebrafish spermatogenesis; 
discovered that brca2 is required for ovarian development in zebrafish; shown that 
the association between reproductive tumorigenesis and brca2 mutation is conserved 
in zebrafish; and demonstrated that tp53 mutation is an important contributor to 
brca2-associated carcinogenesis.  The brca2
Q658X
-mutant zebrafish line represents an 
important resource for studying both gonadogenesis and brca2-associated 
carcinogenesis.  This model has the potential to enable identification of genetic, 
environmental, or chemical modifiers that influence cancer susceptibility, and 
provides a new platform for studying the processes of gonad development and sex 










Amino acid sequence motifs found in zebrafish brca2.  The zebrafish (accession 
number NP_001103864), mouse (accession number NP_001074470), and human 
BRCA2 (accession number NP_000050.2) were compared using MacVector 
(MacVector, Inc.) and sequence motifs were identified using InterProScan
 
(163).  The 
amino acid positions for each motif are given in parentheses.  (A) Alignment of the 
10-residue minimal PALB2-binding motif from human (21-39), mouse (21-39), and 
zebrafish (10-28) BRCA2.  Identical residues are boxed in red.  The arrows indicate 
the core interacting residues Trp31, Phe32, and Leu35
 
(164).  (B) Alignment of the 
zebrafish brca2 BRC Rad51-binding repeat motifs to a consensus sequence from the 
eight human BRCA2 BRC repeats
 
(165).  The positions of the zebrafish BRC repeats 
are: 1 (586-620), 2 (896-928), 3 (1003-1037), 4 (1129-1163), 5 (1238-1272), 6 (1295-
1329), 7 (1361-1395), 8 (1401-1435), 9 (1445-1479), 10 (1488-1522), 11 (1533-
1564), 12 (1573-1607), 13 (1617-1651), 14 (1685-1719).  Residues found in >90% of 
the sequences are boxed in red, >70% in dark grey, and >50% in light grey.  The 
dashes indicate gaps in the alignment or no defined consensus.  (C) Alignment of the 
BRCA2 carboxy-terminal Rad51-binding domain (166) from zebrafish (2796-2831), 
human (3270-3305), and mouse (3193-3228).  Identical residues are boxed in red, and 
residues common in two sequences are boxed in grey.  The arrow indicates the 








Standard Immunohistochemistry Protocol provided by Histoserv, Inc. for detection of 
cytokeratin immunoreactivity in formalin-fixed paraffin-embedded sections. 
 
1. Deparaffinize slides 
2. Wash in distilled water  
3. Pretreat slides at 85ºC for 20 minutes 
4. Incubate in hydrogen peroxide solution for blocking 
5. Was in distilled water wash 
6. Incubate in bovine serum albumin (BSA) solution for blocking 
7. Wash in Tris-buffered-saline-Tween-20 (TBST) buffer 
8. Apply primary antibody – diluent for primary antibody is 1% BSA 
9. Wash in TBST buffer 
10. Apply secondary antibody – diluent for secondary antibody is 1% BSA 
11. Wash in TBST buffer 
12. Apply streptavidin-horseradish-peroxidase solution 
13. Wash in TBST buffer 
14. Develop slides with Diaminobenzidine (DAB) 
15. Counterstain with Hematoxylin 
16. Dehydrate and clear 




















Cherry F GCACCCCAGGCTTTACACTTTATGCTTCC 
Cherry R actcgagCGGCCGCGACTGTAGAATT 

















Lowercase = restriction enzyme recognition sequence 






WHOLE-MOUNT IN SITU HYBRIDIZATION REAGENTS 
WISH hybridization buffer  50% formamide 
 5X SSC 
 5mM EDTA, pH 8.0 
 0.1% Tween-20 
 0.1% CHAPS 
 50µg/ml heparin 
 1mg/ml torula yeast RNA 
 DEPC water 
Maleic acid buffer 
 
 0.1M maleic acid, pH 7.5 
 150mM NaCl 
Wash I 
 
 50% formamide 
 2X SSC 
 0.15% CHAPS 
Wash II 
 
 2X SSC 
 0.3% CHAPS 
Wash III 
 
 0.2X SSC 
 0.3% CHAPS 
Blocking solution 
 
 2% Blocking Reagent (Roche) 
 0.1M maleic acid buffer 
 5% fetal bovine serum 
Working antibody solution 
 
 Fixed embryos, ~100 from gastrula, somite, and segmentation stages 
 0.5 ml blocking solution 
PBTw buffer 
 
 1X PBS 
 0.2% bovine serum albumin 
 0.1% Tween-20 
Staining buffer 
 
 0.1M Tris-HCl, pH 9.5 
 0.1M NaCl 
 50mM MgCl2 
 0.1% Tween-2 
IN SITU HYBRIDIZATION REAGENTS 
ISH hybridization buffer  50% deionized formamide 
 4X SSC 
 10% dextran sulfate 
 5X Denhardt’s solution 
 0.2 mg/ml salmon sperm DNA 
 0.25 mg/ml yeast tRNA 
 DEPC water 
Block buffer 
 
 100mM Tris-HCl, pH 7.5 
 150mM NaCl 
Blocking solution 
 
 1% Blocking Reagent (Roche) 
 5% FBS 
Color buffer 
 
 100mM Tris-HCl, pH 9.5 
 100mM NaCl 




 BCIP/NBT Alkaline Phosphatase Substrate Kit (Vector Labs) 
 Levamisole (Vector Labs), 1 drop/5 ml 
 0.001% Tween-20 
Stop buffer 
 
 10mM Tris-HCl pH 8.0 
 1mM EDTA, pH 8.0 
MISCELLAENOUS REAGENTS 
Acridine Orange solution  5µg/ml Acridine Orange hemi (zinc chloride) salt (Sigma) in ddH2O 
DNA lysis buffer 
 
 10mM Tris-HCl, pH 8.0 
 2mM EDTA 
 0.2% Triton-X100 
DNA extraction buffer 
 
 10mM Tris-HCl, pH 8.4 
 10mM EDTA, pH 8.0 
 200mM NaCl 
 0.5% SDS 
Tricaine methanesulfonate  0.4% tricaine (3-amino benzoic acid ethyl ester; ethyl m-aminobenzoate) 
 1.0% Na2HPO4 
1X Danieau’s medium  58mM NaCl 
 0.7mM KCl 
 0.4mM MgSO4 
 0.6mM Ca(NO3)2 








Wildtype AB* male and female zebrafish were divided into breeding and nonbred 
cohorts.   All cohorts were maintained in sex-segregated tanks, and zebrafish in the 
breeding cohort were bred at biweekly intervals beginning at 3 months of age.  









Wildtype zebrafish embryos were irradiated at 4.5 hpf at the following dose intervals:  
0 Gy, 0.1 Gy, 0.5 Gy, 1.0 Gy, 5.0 Gy, 10.0 Gy, and 20.0 Gy.  60 embryos were 
irradiated at each dose interval.  Irradiated embryos were stained with Acridine 







Zebrafish from an incross of brca2
Q658X
 heterozygotes were irradiated during 
embryogenesis and raised to adulthood.  No significant long-term effects on 
morbidity or mortality were observed in brca2
Q658X
 -mutant zebrafish as compared to 
wildtype siblings. 
  Wildtype 
Specimen Age (mo) Irradiation dose Diagnosis 
1 6.0  0 Gy ND 
2 10.5  0 Gy 1) Cutaneous melanoma (tail) 




Specimen Age (mo) Irradiation dose Diagnosis 
4 13.0 0 Gy 1) Spermatocytic seminoma 
2) Ultimobranchial carcinoma 
5 13.5  5.0 Gy ND 
6 18.0 0 Gy 1) Ultimobranchial adenoma 
2) Severe intracoelomic gas distension 
   brca2
Q658X
 homozygous 
Specimen Age (mo) Irradiation dose Diagnosis 
7 17.0  0 Gy 1) Chronic granulomatous coelomitis, hepatitis, and 
pancreatitis with rare intralesional bacilli 
2) Testicular hypoplasia with arrested spermatogenesis and 
mild germ cell dysplasia 
8 17.5  5.0 Gy ND 
9 6.0  0 Gy 1) Musculoskeletal deformation 
2) Testicular hypoplasia with arrested spermatogenesis 
10 5.5  5.0 Gy 1) Severe granulomatous coelomitis with intralesional fungal 
hyphae and acid-fast bacilli 













 homozygotes demonstrated numerous clusters of 
apoptotic cells in brca2
Q658X














WISH for vasa at 4 dpf in wildtype, brca2
Q658X
 heterozygotes, and brca2
Q658X
 
homozygotes indicated no apparent difference in primordial germ cell numbers or 









WISH with antisense (A) and sense (B) RNA probes for vasa at 24 hpf.  Injected 
embryos received equivalent doses of control (scrambled) morpholino (MO) or dnd 
MO. The absence of vasa-expressing cells in embryos injected with dnd MO 









Hyperplastic, dysplastic, and degenerative changes in hematoxylin and eosin sections 
of testes from adult brca2
Q658X 
homozygous zebrafish.  (A) Testicular tubules are 
lined by numerous germ cells that form multicellular layers (inset, long arrow).  
Multifocally there are dysplastic germ cells with large nuclei, vacuolated chromatin, 
and prominent nucleoli (inset, short arrow).  (B) Testes from brca2
Q658X 
homozygotes 
show segmental degeneration, with loss of spermatocytes in testicular tubules. 
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Humanswith inheritedmutations in BRCA2 are at increased risk for
developing breast and ovarian cancer; however, the relationship
between BRCA2 mutation and these cancers is not understood.
Studies of Brca2 mutation by gene targeting in mice are limited,
given that homozygous Brca2mutation typically leads to early em-
bryonic lethality. We established a zebrafish line with a nonsense
mutation in brca2 exon 11 (brca2Q658X), a mutation similar in loca-
tion and type to BRCA2mutations found in humanswith hereditary
breast and ovarian cancer. brca2Q658X homozygous zebrafish are
viable and survive to adulthood; however, juvenile homozygotes
fail to develop ovaries during sexual differentiation. Instead,
brca2Q658X homozygotes develop as infertile males with meiotic
arrest in spermatocytes. Germ cell migration to the embryonic go-
nadal ridge is unimpaired in brca2Q658X homozygotes; thus, failure
of ovarian development is not due to defects in early establishment
of the embryonic gonad. Homozygous tp53mutation rescues ovar-
ian development in brca2Q658X homozygous zebrafish, reflecting
the importance of germ cell apoptosis in gonad morphogenesis.
Adult brca2Q658X homozygous zebrafish are predisposed to testic-
ular neoplasias. In addition, tumorigenesis in multiple tissues is
significantly accelerated in combination with homozygous tp53
mutation in both brca2Q658X homozygous and brca2Q658X heterozy-
gous zebrafish. These studies reveal critical roles for brca2 in ovar-
ian development and tumorigenesis in reproductive tissues.
gonad development | meiosis | sex determination | fancd1
Inherited mutations in the human breast cancer 2 gene (BRCA2)are a well-established risk factor for developing ovarian cancer
(1, 2). The link between mutations in BRCA2 and ovarian cancer
susceptibility is not understood. Epidemiologic evidence suggests
that mutations in the “ovarian cancer cluster region” in BRCA2
exon 11 are associated with an increased incidence of ovarian
cancer relative to breast cancer in affected families (3, 4). Cancer
risk occurs in heterozygous carriers of BRCA2mutations, but loss
of heterozygosity is frequently observed in cancer cells (5).
BRCA2 is a component of the DNA repair machinery and
mediates homologous recombination in somatic cells and mei-
otic recombination in germ cells (6, 7). Mutations in BRCA2
perturb double-strand DNA break repair, and various chromo-
somal aberrations are observed in BRCA2-deficient cells (6–8).
In vivo studies of Brca2 mutation in mouse models are limited,
given that homozygous loss of Brca2 by gene targeting leads to
decreased cellular proliferation, developmental arrest, and early
embryonic lethality in most instances (9, 10).
To investigate the role of brca2 in development and tumori-
genesis, we established a zebrafish line with a nonsense mutation
in brca2 exon 11 (brca2Q658X), a mutation similar in location and
type to BRCA2 mutations in humans with hereditary breast and
ovarian cancer (11). We report that brca2 is essential for zebrafish
ovarian development. Homozygous brca2Q658X mutation leads to
an all-male phenotype in zebrafish, which can be abrogated by
concomitant loss of tp53. brca2 also functions as a tumor-
suppressor gene in zebrafish. Adult brca2Q658X homozygotes de-
velop testicular tumors, and tumorigenesis is accelerated in mul-
tiple tissues by homozygous tp53 mutation in both brca2Q658X
heterozygotes and homozygotes. Thus, brca2 plays critical roles in
both ovarian development and cancer susceptibility.
Results
brca2 Is Expressed During Embryogenesis and in Adult Gonads.
Zebrafish brca2 is homologous to human BRCA2, with con-
served structural organization and a large exon 11 in both species
(12). The characteristic BRC repeats located in exon 11 of hu-
man BRCA2 are also found in exon 11 of the zebrafish brca2
gene (Fig. 1A and Fig. S1).
Whole-mount in situ hybridization (WISH) for brca2 on WT
embryos from the two-cell stage through 24 h postfertilization
(hpf) showed abundant expression of brca2 in early cleavage-
stage embryos (Fig. S2A), corresponding to maternal mRNA
produced during oogenesis (13). Thus, maternally provided
brca2 is available for DNA repair before zygotic transcription
begins. At 24 hpf, brca2 expression was highest in the developing
brain, eye, and ear (Fig. S2A). These findings complement
a previous study of brca2 expression during zebrafish embryo-
genesis (14). In situ hybridization for brca2 in adult WT zebrafish
ovaries demonstrated brca2 expression in developing and mature
oocytes, with the strongest expression seen in the most mature
oocytes (Fig. S2B). In adult WT testes, brca2 was expressed in
spermatogonia and developing spermatocytes, but not in mature
spermatozoa (Fig. S2B).
brca2Mutant Zebrafish Are Phenotypically Male and Exhibit Aberrant
Spermatogenesis. To establish a brca2mutant zebrafish model, we
screened an ethylnitrosourea (ENU)-mutagenized library for
mutations in brca2 exon 11 by resequencing and identified a
zebrafish line carrying a C-to-T point mutation that produces a
glutamine (Q) to stop codon (X) change (Fig. 1A). Multiple
incrosses of brca2Q658X heterozygotes yielded WT, heterozygous,
and homozygous mutant zebrafish in Mendelian ratios, indicating
that brca2Q658X homozygotes are fully viable (Table S1).
At sexual maturity, all brca2Q658X homozygotes were pheno-
typically male, whereas both the WT and brca2Q658X heterozy-
gous cohorts included similar ratios of male and female zebrafish
(Fig. 1B). brca2Q658X homozygotes induced egg laying in fer-
tile WT female zebrafish, but eggs collected from these crosses
were unfertilized.
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On histological examination of the gonads, adult WT and
brca2Q658X heterozygotes had either mature ovaries or testes,
and gonadal sex was consistent with predicted sex based on
physical features and behavior (Fig. 1 B and C). In contrast, all
brca2Q658X homozygotes had only testes (Fig. 1C). Spermato-
genesis was arrested in testes from brca2Q658X homozygotes, with
only spermatogonia and primary spermatocytes present (Fig.
1C). Spermatogenesis was complete in testes from male WT and
brca2Q658X heterozygotes (Fig. 1C). The ovaries from female WT
and brca2Q658X heterozygotes were morphologically similar, with
complete oocyte development and maturation (Fig. 1C).
brca2 Mutant Zebrafish Do Not Develop Juvenile Ovaries. To de-
termine the stage at which brca2 mutation affects sexual differ-
entiation, we examined gonads from juvenile zebrafish of each
brca2 genotype by histology at intervals between 21 d and 51
d postfertilization (dpf). During this period, all zebrafish normally
develop “juvenile ovaries” that contain gonocytes, early meiotic
oocytes, and perinucleolar oocytes (15, 16). With maturation,
males undergo oocyte loss and proliferation of spermatogonia
and spermatocytes, whereas females continue to experience oo-
cyte proliferation and differentiation (15, 16).
Gonadal development in WT and brca2Q658X heterozygotes
was similar at all time points. At 21 dpf, the gonads from
zebrafish of both genotypes were undifferentiated and contained
gonocytes and scant stroma (Fig. 2A). At 31 dpf, gonads were
classified into four morphologic types: undifferentiated (similar
to gonads at 21 dpf), juvenile ovary, presumptive ovary, and
presumptive testis (Fig. 2B). Juvenile ovaries were distinguished
by the presence of perinucleolar oocytes (Fig. 2B, short arrows).
Presumptive ovaries exhibited maturing oocytes, whereas pre-
sumptive testes exhibited developing spermatogonial cysts with
reduction or loss of perinucleolar oocytes (Fig. 2B). By 41 and 51
dpf, definitive ovarian or testicular differentiation was apparent
in WT and brca2Q658X heterozygotes (Fig. 2 C and D).
In contrast, oocyte differentiation was not observed in gonads
from brca2Q658X homozygotes at any time point. At 21 dpf,
gonads from brca2Q658X homozygotes were similar to gonads
from WT and brca2Q658X heterozygotes (Fig. 2A). At 31 dpf,
gonads from brca2Q658X homozygotes were classified as un-
differentiated or presumptive testes (Fig. 2B). The presumptive
testes contained germ cells and clusters of round cells encircled
by somatic cells, consistent with developing spermatogonial cysts.
Gonads from some brca2Q658X homozygotes contained putative
premeiotic germ cells (Fig. 2B, arrowheads), which were not
Fig. 1. Zebrafish brca2 structure and zebrafish brca2Q658X mutation. (A)
Schematic of zebrafish brca2 (Upper) compared with human BRCA2 (Lower).
The zebrafish brca2 gene [National Center for Biotechnology Information
(NCBI) sequence NC_007126.4] has 16,583 base pairs with 27 exons and
encodes a 2874-aa protein (NCBI sequence NP_001103864). Conserved
domains include the Rad51-binding BRC repeats (red bars) and the DNA-
binding domain (dark-blue box). The zebrafish brca2Q658X mutation (C1971T;
Q658X) described herein is shown relative to its position within exon 11. (B)
WT and brca2Q658X heterozygotes exhibit distinctly male or female pheno-
types, whereas brca2Q658X homozygotes are phenotypically male. (C) Gonads
from zebrafish of each genotype reflect observed male or female pheno-
types in B. Spermatogenesis is complete in testes from WT and brca2Q658X
heterozygotes. Testes from brca2Q658X homozygotes contain only sper-
matogonia and primary spermatocytes. Ovaries from WT and brca2Q658X
heterozygotes are similar and contain developing and mature oocytes. sg,
spermatagonia; sc, spermatocytes; sz, spermatozoa; I, stage I oocyte; II, stage
II oocyte; III, stage III oocyte. (Scale bars: 50 μm for sections of testis; 250 μm
for sections of ovaries.)
Fig. 2. Failure of ovarian development occurs in brca2Q658X homozygotes
during gonadal development. (A) Gonads from WT, brca2Q658X hetero-
zygotes, and brca2Q658X homozygotes are indistinguishable at 21 dpf. (B) At
31 dpf, WT and brca2Q658X heterozygotes exhibit juvenile ovaries, early tes-
ticular differentiation, or early ovarian differentiation, whereas brca2Q658X
homozygotes exhibit only early testicular differentiation. Perinucleolar
oocytes in juvenile ovaries are indicated by short arrows; putative premeiotic
germ cells are indicated by arrowheads. (C and D) At 41 and 51 dpf, WT and
brca2Q658X heterozygotes exhibit continued maturation of testes or ovaries,
whereas brca2Q658X homozygotes exhibit only testicular development. go,
gonocyte; sgc, spermatogonial cyst; oc, oocyte; sc, spermatocyst; I, stage I
oocyte; II, stage II oocyte. (Scale bars: 50 μm; 100 μm in 51 dpf ovaries.)
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observed in gonads from WT or brca2Q658X heterozygotes. Few
spermatocysts were observed in developing testes at 41 dpf in
brca2Q658X homozygotes compared with WT and brca2Q658X
heterozygotes (Fig. 2C). By 51 dpf, brca2Q658X homozygous
testes contained only spermatogonia and primary spermatocytes,
with fewer spermatocysts compared with WT and brca2Q658X
heterozygotes (Fig. 2D). No perinucleolar oocytes were observed
in developing gonads from brca2Q658X homozygotes at any
time point.
Germ Cell Designation, Development, and Survival in brca2 Mutant
Zebrafish. Development of all-male populations has been de-
scribed in zebrafish with embryonic loss of primordial germ cells
(PGCs) or failure of PGCs to migrate to the embryonic gonadal
ridge (17, 18). Thus, we evaluated embryos from incrosses of
brca2Q658X heterozygous zebrafish for the presence and appro-
priate localization of PGCs at 24 hpf by WISH for the germ cell
marker vasa (Fig. 3A). Expression of vasa in 24-hpf embryos in-
dicated no apparent difference in PGC numbers or localization in
WT, brca2Q658X heterozygotes, or brca2Q658X homozygotes (Fig.
3A). Similar results were observed at 4 dpf (Fig. S3).
Although brca2Q658X mutation did not appear to affect em-
bryonic PGC designation, meiotic progression in germ cells was
arrested in brca2Q658X homozygotes. Testes from adult brca2Q658X
homozygotes showed increased numbers of spermatocysts con-
taining spermatocytes with meiotic nuclear morphology (Fig. 3B).
The numbers of spermatocysts containing spermatocytes in mei-
osis were statistically significantly higher in testes from adult
brca2Q658X homozygotes compared with testes from WT (P =
0.0026) and brca2Q658X heterozygotes (P = 0.0009) (Table S2).
Meiotic arrest in testes from adult brca2Q658X homozygotes
was accompanied by extensive spermatocyte apoptosis; in con-
trast, apoptotic cells were rare in testes from adult WT and
brca2Q658X heterozygotes. TUNEL assay (Fig. 3C) and immu-
nohistochemistry for cleaved caspase-3 (Fig. S4) demonstrated
multiple apoptotic spermatocytes in adult brca2Q658X homo-
zygotes testes, with apoptotic spermatocytes often forming dis-
tinct cell clusters (Fig. 3C, Inset).
Homozygous Loss of tp53 Rescues Ovarian Development in brca2
Mutant Zebrafish. To examine how germ cell apoptosis might im-
pact gonad development in brca2 mutant zebrafish, we crossed
brca2Q658X heterozygotes with tp53M214K homozygotes (19). We
subsequently incrossed brca2Q658X heterozygous;tp53M214K het-
erozygous zebrafish, and raised the progeny to adulthood.
Histological examination of the gonads from seven adult
brca2Q658X homozygous;tp53M214K homozygous zebrafish re-
vealed that two zebrafish had developed ovaries (Fig. 3D). Oo-
genesis appeared to be complete in the female brca2Q658X ho-
mozygous;tp53M214K homozygous zebrafish; however, the ovaries
contained multiple binucleate oocytes (Fig. 3D, Inset), which
were not seen in female brca2Q658X heterozygotes or WT
zebrafish.
brca2 Mutant Zebrafish Are Predisposed to Testicular Neoplasia.
Because BRCA2 mutations in humans are associated pre-
dominantly with cancer development in reproductive tissues, we
histologically evaluated the testes from aged adult brca2Q658X
homozygotes for tumor development. At 10–16mo of age, 4 out of
13 (31%) brca2Q658X homozygotes developed testicular neoplasia
(Fig. 4). Testicular tumors were of both somatic cell and germ cell
origin and included undifferentiated stromal cell tumors (Fig. 4 A
and B), a papillary cystadenoma (Fig. 4C), and a seminoma (Fig.
4D). Other changes in testes from aged adult brca2Q658X homo-
zygotes included germ cell hyperplasia and dysplasia, as well as
segmental testicular degeneration (Fig. S5).
In contrast, no testicular tumors were observed in age-
matched cohorts of WT (n = 12) and brca2Q658X heterozygotes
(n = 12). The hyperplastic, dysplastic, and degenerative changes
observed in testes from brca2Q658X homozygotes were not seen in
testes from WT and brca2Q658X heterozygotes.
Collaborative Effects of tp53 and brca2 Mutations on Tumorigenesis.
Analysis of tumorigenesis in zebrafish from an incross of brca2Q658X
heterozygous;tp53M214K heterozygous zebrafish revealed that com-
bined mutations in brca2 and tp53 accelerated the onset of tumor
development (Fig. 4E and Table S3). The mean age at tumor onset
was statistically significantly lower in both brca2Q658X homozygous;
tp53M214K homozygous zebrafish and brca2Q658X heterozygous;
tp53M214K homozygous zebrafish compared with the tp53M214K ho-
mozygous parent line (Table S3). Of all tumor-bearing zebrafish
collected from the brca2Q658X heterozygous;tp53M214K heterozy-
gous zebrafish incross, only two were brca2Q658X WT;tp53M214K
homozygous zebrafish, and their ages at tumor onset were similar to
those observed in the tp53M214K homozygous parent line (Table S4).
Fig. 3. Germ cell specification, development, and survival in embryonic
and adult brca2Q658X homozygotes. (A) WISH with antisense (AS) and
sense (S) RNA probes for vasa indicates appropriate migration and colo-
nization of the gonadal ridge in WT, brca2Q658X heterozygous, and
brca2Q658X homozygous embryos. (B) Testes from WT, brca2Q658X heter-
ozygotes, and brca2Q658X homozygotes show spermatocysts containing
meiotic spermatocytes. (C ) TUNEL staining of testes from WT, brca2Q658X
heterozygotes, and brca2Q658X homozygotes. Multiple clusters of apo-
ptotic spermatocytes are present in testes from brca2Q658X homozygotes
(Inset). (D) Homozygous tp53M214K mutation rescues ovarian develop-
ment in brca2Q658X homozygotes, but female brca2Q658X homozygous;
tp53M214K homozygous zebrafish develop binucleate oocytes (Inset). sc,
spermatocyst; msc, meiotic spermatocyst; I, type I oocyte; II, type II oocyte;
III, type III oocyte. (Scale bars: 25 μm in B, 100 μm in C, and 500 μm in D.)















The majority of tumors observed in both brca2Q658X hetero-
zygous;tp53M214K homozygous zebrafish and brca2Q658X homo-
zygous;tp53M214K homozygous zebrafish were malignant peri-
pheral nerve sheath tumors (Table S4). Interestingly, in three out
of seven female brca2Q658X heterozygous;tp53M214K homozygous
zebrafish, the ovaries appeared to be the primary site of tumor
development (Fig. 4F). Tumor development in one of two fe-
male brca2Q658X homozygous;tp53M214K homozygous zebrafish
also appeared to mainly involve the ovary (Table S4). Primary
tumorigenesis in the gonads was not typical of a subset of
tp53M214K homozygous zebrafish evaluated histologically (Table
S4) and was not reported in characterization of the tp53M214K
zebrafish line (19). In multiple instances, zebrafish developed
tumors in more than one anatomic location and/or developed
more than one type of tumor (Table S4).
Discussion
Previous studies of Brca2 mutation in murine models have been
limited due to the preponderance of early embryonic lethality
associated with homozygous loss of Brca2 (10). In zebrafish, we
find that homozygous loss of brca2 does not affect embryonic
survival. This difference may reflect the relatively late onset of
zygotic gene transcription in zebrafish embryos, which begins in
cleavage cycle 10 (20). Given that maternal brca2 is abundant in
early-stage zebrafish embryos, it is likely that maternal RNA
sustains brca2Q658X homozygotes during early development.
BRCA2 is required in germ cells for the repair of double-
strand DNA breaks generated during prophase of meiosis I, with
loss of BRCA2 resulting in meiotic arrest (21, 22). Our analyses
of brca2Q658X homozygous zebrafish demonstrate a conserved
role for brca2 in zebrafish germ cell development and spermato-
genesis. Histological analyses of more than 90 zebrafish of each
genotype derived from 17 different clutches confirmed that the
testicular phenotype described herein was correlated with ho-
mozygous brca2Q658X mutation in all cases, and was maintained
after three outcrosses to WT zebrafish. The patterns of TUNEL
staining and cleaved caspase-3 immunoreactivity in brca2Q658X
homozygous testes appear to reflect apoptosis of spermatocyte
Fig. 4. brca2Q658X homozygotes are predisposed to testicular neoplasias, and brca2Q658X and tp53M214K mutations have collaborative effects on tumori-
genesis. (A) Undifferentiated stromal cell tumor from a brca2Q658X homozygote. (B) Undifferentiated stromal cell tumor from a brca2Q658X homozygote with
irregular bundles around poorly defined small tubular structures (Inset). (C) Papillary cystadenoma from a brca2Q658X homozygote. (D) Seminoma from
a brca2Q658X homozygote. (E) Age at tumor onset is significantly lower in both brca2Q658X homozygous;tp53M214K homozygous zebrafish and brca2Q658X
heterozygous;tp53M214K homozygous zebrafish compared with the tp53M214K homozygous zebrafish parent line. (F) The ovary is a primary site for tumor
development in brca2Q658X heterozygous;tp53M214K homozygous zebrafish, with oocyte entrapment (Inset). oc, oocyte; cr, cranial; d, dorsal; v, ventral; sb,
swim bladder. (Scale bars: 100 μm in A and B; 200 μm in C and D; 1,000 μm in F; 50 μm in the Insets in A, B, C, and D; 100 μm in the Inset in F.)
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clones, because zebrafish spermatocytes are clonally derived from
a single germ cell and organized into discrete groups known as
spermatocysts (23).
These studies also reveal an important role for brca2 in
ovarian development, raising questions about the participation
of brca2 in PGC–stromal cell signaling in the immature gonad.
BRCA2, also known as FANC-D1, is a member of the Fanconi
anemia (FA) family of proteins that regulate DNA damage re-
sponse and repair (24). Interestingly, gonadal dysmorphogenesis
and hypogonadism are observed in some patients with mutations
in various FA genes (25). Hypogonadism and failure of germ cell
maturation also have been reported in mouse models with
mutations in several FA genes, including a Brca2-deficient mouse
model that was rescued with human BRCA2 (22, 26).
brca2 mutation in zebrafish did not affect PGC specification or
gonadal colonization in embryos. However, the finding that ho-
mozygous tp53 mutation rescued ovarian development in a small
number of brca2Q658X homozygotes indicates that germ cell apo-
ptosis is an important contributor to the failure of ovarian de-
velopment observed in brca2Q658X homozygotes. PGCs can
significantly affect zebrafish gonad development and sex de-
termination. Germ cell apoptosis is an important feature of male
gonad development (27), and germ cell depletion by gene muta-
tion or knockdown generates predominantly male zebrafish pop-
ulations with structurally and functionally male gonads (17, 18).
Gonad development in brca2Q658X homozygotes also may be
influenced by disrupted meiosis in germ cells, because meiotic
progression is required in developing female gonads. In WT ani-
mals, including starfish, sea limpets, and Xenopus species, female
germ cells initiate meiosis during embryogenesis, whereas male
germ cells remain quiescent until sexual maturity (28, 29); thus,
the temporal requirements for BRCA2may differ in female versus
male gonads. Given that germ cells from brca2Q658X homozygous
embryos are likely to be meiotically incompetent, failure of mei-
otic progression in brca2-deficient germ cells during embryogen-
esis might influence stromal differentiation toward testicular
development. Thus, the combined effects of germ cell apoptosis
and meiotic failure might be the underlying mechanisms that
prevent ovarian development in brca2Q658X homozygotes.
Interestingly, multiple binucleate oocytes were present in the
rescued brca2Q658X homozygous;tp53M214K homozygous ovaries.
A role for BRCA2 in cytokinesis has been suggested, with BRCA2
knockdown or loss resulting in abnormal cell division (30). Al-
though this issue remains controversial (31), our findings support
an association betweenBRCA2mutation and aberrant cytokinesis.
The impact of BRCA2 mutation on cancer susceptibility, par-
ticularly in reproductive tissues, is also conserved in zebrafish.
Adult brca2Q658X homozygotes were predisposed to testicular
tumors, which were predominantly of somatic cell origin and were
not observed in age-matched male siblings. These types of tes-
ticular tumors have not been reported previously in zebrafish.
Concomitant homozygous tp53M214K mutation accelerates tu-
morigenesis in multiple tissues in both brca2Q658X heterozygotes
and brca2Q658X homozygotes. Themajority of zebrafish developed
malignant peripheral nerve sheath tumors, similar to those de-
scribed previously in tp53M214K homozygotes (19); however,
a tendency for primary tumor development in the ovary was noted
in female brca2Q658X heterozygous;tp53M214K homozygous and
brca2Q658X homozygous;tp53M214K homozygous zebrafish. These
observations, although limited in number, suggest a specific role
for brca2 mutation in gonad tumorigenesis and imply collabora-
tive effects of tp53 and brca2 mutations on tumorigenesis.
Zebrafish with a homozygous mutation of fancl, another mem-
berof theFA family, develop as fertilemaleswith somephenotypic
similarities to brca2Q658X homozygotes (32). Male zebrafish with
a homozygous mutation of the mismatch repair gene mlh1 share
some of these characteristics as well (33). Both of these genes are
involved in DNA repair; FANCL participates in the FA DNA
damage response pathway (34), whereas MLH1 mediates cross-
over during prophase I (35). Interestingly, an mlh1 mutation in
zebrafish does not prevent ovarian development (33), possibly
because some germ cells are able to complete meiosis in male and
female homozygotes (33, 36). These previous studies, along with the
data presented herein, imply that germ cell survival and completion
of meiosis are critical factors in zebrafish gonad morphogenesis.
Importantly, mutations in fancl and mlh1 are not associated with
reproductive tumorigenesis or aberrant ovarian morphology in ze-
brafish (32, 33). Thus, brca2 mutation uniquely impacts gonadal
pathophysiology in zebrafish.
Our findings indicate that brca2 is required for ovarian de-
velopment in zebrafish and plays an essential role in zebrafish
spermatogenesis. They also show that the propensity for tumor-
igenesis in reproductive tissues in association with BRCA2 mu-
tation appears to be conserved in zebrafish. In humans, the role
for BRCA2 in ovarian development and the effects of BRCA2
mutation on intercellular signaling in the gonad remain unknown.
Mammalian germ cells appear to play a significant role in both
ovarian development and maintenance of the ovarian phenotype
(37). Our studies suggest that BRCA2 might be of importance in
intercellular interactions in both developing and mature gonads.
The implications for BRCA2-associated ovarian cancer are not
yet clear; however, these observations provide important insights
into how germ cell–stromal cell interactions in the ovary might be
related to cancer susceptibility.
Materials and Methods
Zebrafish Maintenance. All of the experiments with zebrafish were approved
by the National Cancer Institute’s Animal Care and Use Committee.
WISH of Zebrafish Embryos. Embryos from incrosses of AB* zebrafish were
used for analyses of WT brca2 expression. Embryos from incrosses of
brca2Q658X heterozygous zebrafish were used for analyses of vasa expres-
sion. Embryos were processed routinely for WISH experiments (see SI
Materials and Methods).
In Situ Hybridization of Adult Zebrafish Gonads. Adult AB* zebrafish were
processed routinely for analysis of WT brca2 expression by in situ hybrid-
ization (see SI Materials and Methods).
Identification and Establishment of brca2Q658X Mutant Zebrafish Line. A pre-
viously established ENU-mutagenized library (38) was screened by PCR and
sequencing with overlapping primer pairs spanning zebrafish brca2 exon 11.
The zebrafish brca2Q658X mutant line was identified by analysis of the se-
quence data using PolyPhred and recovered by in vitro fertilization as de-
scribed previously (38). In the Zebrafish Model Organism Database (ZFIN),
the mutant allele designation for this zebrafish line is brca2hg5.
Histological Analyses. Zebrafish were euthanized with tricaine methanesul-
fonate and fixed in 4% paraformaldehyde at 4 °C for a minimum of 24 h
before being transferred to 70% ethanol. Specimens were processed rou-
tinely for paraffin embedding and preparation of 5-μm H&E-stained sec-
tions (Histoserv).
Histological Analyses of Zebrafish Testes by TUNEL Assay. Testes from 10 adult
males (5.5 mo of age) of each genotype were dissected and grouped by
genotype for fixation as described above. Sections were processed routinely
for TUNEL labeling (see SI Materials and Methods).
Histological Analyses of Zebrafish Testes by Immunohistochemistry for Cleaved
Caspase-3. Testes from 10 adult males (5.5 mo of age) of each genotype were
dissected and grouped by genotype for fixation as described above. Sections
were processed routinely for immunohistochemistry (see SI Materials
and Methods).
Introduction of tp53M214K Mutation. Zebrafish embryos homozygous for the
tp53M214K mutation were acquired from the Zebrafish International Re-
source Center. Adult tp53M214K homozygotes were crossed with brca2Q658X
heterozygotes to establish a cohort of brca2Q658X heterozygous;tp53M214K
heterozygous zebrafish, which were subsequently incrossed.
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SI Materials and Methods
Histological Staging of Zebrafish Specimens. Staging of zebrafish
embryos, ovaries, and testes was performed as described pre-
viously (1–3).
WISH of Zebrafish Embryos. The brca2 probe contained a 3.2-kb
portion of the 3′ end of the cDNA, and the vasa probe contained
the 3′ 549 bases of the cDNA. WISH experiments were per-
formed as described previously (4, 5), with modifications (see
below). Embryos used for genotyping after WISH were prepared
as described previously (6), with minor modifications. Approxi-
mately 50 embryos were analyzed per developmental stage from
three independent experiments. For vasa expression, 25–35
embryos from two independent experiments were imaged in-
dividually and then genotyped for the brca2Q658X mutation.
Modifications to the WISH Protocol. The following modifications
were made to the WISH protocol: (i) Tween 20 was eliminated
from prehybridization washes; (ii) the hybridization buffer in-
cluded 0.1% CHAPS and 0.5 mM EDTA; (iii) hybridization re-
actions were incubated at 60 °C or 65 °C; (iv) posthybridization
washes included 0.3% CHAPS in 2× SSC; and (v) proteinase K
digestion, acetic anhydride treatment, and RNase treatment were
eliminated.
In Situ Hybridization of Adult Zebrafish Gonads. The brca2 probe
contained the 3′ 330 bases of the cDNA. Unstained sections were
processed for in situ hybridization as described previously (7),
with the following modifications: (i) Zebrafish were fixed in 4%
paraformaldehyde at 4 °C for 24 h, transferred to 70% ethanol,
and embedded in paraffin, and 5-μm unstained sections were
prepared; (ii) sections were treated with proteinase K (5 μg/mL or
10 μg/mL) at 37 °C; (iii) the hybridization buffer contained 0.2
mg/mL Sonicated Salmon Sperm DNA (Stratagene); (iv) hy-
bridization reactions were conducted at 50 °C or 60 °C; (v) 5× In
Situ Hybridization Blocking Solution (Vector Laboratories) was
used for blocking; (vi) the BCIP/NBT Alkaline Phosphate Sub-
strate Kit IV (Vector Laboratories) was used for detection;
and (vii) slides were briefly dehydrated in ethanol grades be-
fore coverslipping.
Genotyping. Tail amputation and DNA extraction for genotyping
were performed as described previously (5), with minor mod-
ifications. Tissue was digested in 100 μL of DNA extraction
buffer [10 mM Tris-HCl (pH 8.0), 2 mM EDTA, 0.2% Triton X-
100] with 0.2 mg/mL of proteinase K (Fermentas) at 50–55 °C for
a minimum of 2 h, followed by 10 min at 95 °C. A brca2 fragment
was amplified by PCR with primers designed to create an AluI
restriction site based on the presence of the brca2Q658X point
mutation. PCR products were incubated with AluI digestion
buffer (0.07 U/μL AluI in 1× Tango buffer; Fermentas) at 37 °C
for a minimum of 2 h.
Histological Analysis of Gonadal Development. Juvenile zebrafish
were collected at 21, 31, 41, and 51 dpf and euthanized, genotyped,
and individuallyfixedas described above. Specimenswere grouped
in tissue cassettes by genotype. The 21-dpf juveniles were em-
bedded in 2% agarose before being placed in tissue cassettes. Ten
sections were screened per group; specimens were assessed for the
presence of gonadal tissue, presence of identifiable perinucleolar
oocytes in gonads (signifying juvenile ovary formation), presence
of spermatogonia in spermatogonial cysts (signifying testicular
differentiation), and proliferation and differentiation of oocytes
(signifying ovarian differentiation).
Histological Analyses of Meiosis in Spermatocytes. Testes from 10
adult males (age 5.5 mo) of each genotype were dissected and
grouped by genotype for fixation as described above. To de-
termine the total percentage of spermatocysts containing cells
in meiosis, five tubules were randomly selected from each of 10
testis sections, for a total of 50 tubules. Tubules in which the
tubular lumen and margins could not be reasonably ascertained
were disregarded, and sections without at least five well-defined
tubules in a cross-sectionwere not included. For each tubule, the
total number of spermatocysts was counted, and the number of
spermatocysts containing spermatocytes with meiotic figures
was recorded (Table S2). The numbers of spermatocysts per
tubule from testes of each brca2 genotype were compared using
an unpaired t test (Table S2). The numbers of meiotic sper-
matocysts per tubule from testes of each brca2 genotype were
compared using an unpaired t test with Welch’s correction
(Table S2).
TUNEL Assay on Zebrafish Testes. TUNEL labeling was performed
on 5-μm unstained sections with a commercially available kit (In
Situ Cell Death Detection Kit, AP; Roche Diagnostics). After
TUNEL labeling, sections were counterstained with Nuclear Fast
Red Solution (Sigma-Aldrich) and mounted with Clear-Mount
(Electron Microscopy Services). TUNEL assays were performed
with each sample set in three independent experiments.
Immunohistochemistry for Cleaved Caspase-3. Sections were
deparaffinized in xylene, rehydrated through a series of ethanol
grades, and incubated in 3% H2O2/70% methanol to block en-
dogenous peroxidase activity. For antigen retrieval, sections were
incubated in 1× Target Retrieval Solution (DAKO) with steam.
Protein block (DAKO) and normal goat serum were used for
blocking, and the Vector Avidin/Biotin Blocking Kit (Vector
Laboratories) was used to block endogenous biotin. Detection of
cleaved caspase-3 was done using a rabbit polyclonal anti–cleaved
caspase-3 antibody (1:200 dilution; Cell Signaling) with a goat
anti-rabbit biotinylated secondary antibody (1:400 dilution; DA-
KO). Detection was achieved by incubating sections with a pre-
formed avidin–biotinylated enzyme complex (Vectastain ABC
Kit; Vector Laboratories), followed by application of 3,3′-dia-
minobenzidine tetrahydrochloride (DAB-Plus Substrate Kit; In-
vitrogen). After detection, sections were counterstained with
Mayer’s hematoxylin solution (Sigma-Aldrich), dehydrated, and
coverslipped.
Evaluation of Tumor Incidence in Adult Zebrafish. Adult zebrafish
were regularly monitored for evidence of morbidity or overt
tumor development. Tumor development in the tp53M214K ho-
mozygous zebrafish parent line was defined by observation of
macroscopically identifiable tumors, and a subset was also
screened by histology to confirm diagnosis. Progeny from an
incross of brca2Q658X heterozygous;tp53M214K heterozygous ze-
brafish were evaluated for macroscopic tumor development and
by histology. The ages at tumor onset in each genotype of ze-
brafish were compared using an unpaired t test (Table S3).
Image Acquisition. Embryos were imaged with a Leica MZ16
stereomicroscope and Leica DFC420 camera with Leica Imaging
Suite. Histological sections were imaged with an Olympus BX41
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and Diagnostic Instruments 14.2 color mosaic camera with SPOT
version 4.6.4.3 imaging software (SPOT Imaging Solutions).
Primer Sequences for brca2Q658X Genotyping by PCR and Restriction
Digest.
Forward primer (mismatched bases in italics): TCCTGCAC-
CAAGACCCCCTGTAAGC
Reverse primer: CTGTCAAAGTGCCATTTTCTTCAAG
Primer Sequences for brca2Q658X Genotyping by Sequencing.
Forward primer: TGAGGCTATAGTAAAGGCAAAGGC
Reverse primer: GTCTTGGAAGCATCACTAACACTCAC
Primer Sequences for tp53M214K Genotyping by Sequencing.
Forward primer: CATATTCACAGACCACCAGCCC
Reverse primer: TCACACTAAAAGCATACCTCGCC
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Fig. S1. Amino acid sequence motifs found in zebrafish brca2. The zebrafish (accession no. NP_001103864), mouse (accession no. NP_001074470), and human
BRCA2 (accession no. NP_000050.2) were compared using MacVector (MacVector), and sequence motifs were identified using InterProScan (8). The amino acid
positions for each motif are given in parentheses. (A) Alignment of the 10-residue minimal PALB2-binding motif from human (21–39), mouse (21–39), and
zebrafish (10–28) BRCA2. Identical residues are boxed in red. The arrows indicate the core interacting residues Trp31, Phe32, and Leu35 (9). (B) Alignment of
the zebrafish brca2 BRC Rad51-binding repeat motifs to a consensus sequence from the eight human BRCA2 BRC repeats (10). The positions of the zebrafish
BRC repeats are as follows: 1, 586–620; 2, 896–928; 3, 1003–1037; 4, 1129–1163; 5, 1238–1272; 6, 1295–1329; 7, 1361–1395; 8, 1401–1435; 9, 1445–1479; 10,
1488–1522; 11, 1533–1564; 12, 1573–1607; 13, 1617–1651; 14, 1685–1719. Residues found in >90% of the sequences are boxed in red, those found in >70% are
boxed in dark gray, and those found in >50% are boxed in light gray. The dashes indicate gaps in the alignment or no defined consensus. (C) Alignment of the
BRCA2 carboxyl-terminal Rad51-binding domain (11) from zebrafish (2796–2831), human (3270–3305), and mouse (3193–3228). Identical residues are boxed in
red, and residues common in two sequences are boxed in gray. The arrow indicates the conserved CDK phosphorylation site (12).
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Fig. S2. brca2 expression in WT embryonic and adult zebrafish. (A) WISH for brca2 expression in zebrafish embryos with antisense (AS; Upper) and sense (S;
Lower) probes at the indicated stages demonstrates expression of brca2 throughout embryogenesis. (B) In situ hybridization for brca2 expression in sections of
adult zebrafish ovary and testis with AS (Middle) and S probes (Right) indicates that brca2 is expressed in oocytes, spermatogonia, and spermatocytes (arrows).
H&E-stained sections of ovary (Left, Upper) and testis (Left, Lower) are provided for anatomic reference. I, stage I oocyte; II, stage II oocyte; III, stage III oocyte;
sg, spermatogonia; sc, spermatocytes; sz, spermatozoa. (Scale bars: 100 μm for ovary; 50 μm for testis.)
Fig. S3. Germ cell specification and localization at 4 dpf. WISH for the germ cell marker vasa indicates similar numbers and localization of PGCs at 4 dpf in
zebrafish embryos of each brca2 genotype. Arrows indicate vasa-expressing PGCs. AS, antisense RNA probe; S, sense RNA probe.
Fig. S4. Immunohistochemistry for cleaved caspase-3 in testes from WT, brca2Q658X heterozygous, and brca2Q658X homozygous zebrafish. Multiple clusters of
apoptotic spermatocytes are present in testes from brca2Q658X homozygotes, whereas few individual apoptotic cells are present in testes from WT and
brca2Q658X heterozygotes. (Scale bars: 100 μm.)
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Fig. S5. Hyperplastic, dysplastic, and degenerative changes in H&E-stained sections of testes from adult brca2Q658X homozygous zebrafish. (A) Testicular
tubules are lined by numerous germ cells that form multicellular layers (Inset, long arrow). Multifocally, dysplastic germ cells with large nuclei, vacuolated
chromatin, and prominent nucleoli are seen (Inset, short arrow). (B) Testes from brca2Q658X homozygotes show segmental degeneration, with loss of sper-
matocytes in testicular tubules. (Scale bars: 100 μm in A; 200 μm in B; 50 μm in the Inset in A.)
Table S1. Genotypes of progeny from incrosses of brca2Q658X heterozygotes conform to
Mendelian ratios
WT brca2Q658X heterozygotes brca2Q658X homozygotes
n 221 402 213
Actual 26.4% 48.1% 25.5%
Expected 25% 50% 25%
Zebrafish were genotyped as juveniles or adults, and data were collected on zebrafish derived from 12 differ-
ent incrosses of brca2Q658X heterozygous zebrafish. The percentages of actual genotypes were not statistically
significantly different from expected genotypes (χ2 = 1.378; P = 0.504).








WT zebrafish 338 15 4%
Brca2Q658X heterozygous zebrafish 364 14 4%
Brca2Q658X homozygous zebrafish 351 38 11%
Comparisons P value P value
WT and brca2Q658X heterozygous zebrafish 0.2867 0.8422
WT and brca2Q658X homozygous zebrafish 0.5074 0.0026
Brca2Q658X heterozygous and brca2Q658Xhomozygous zebrafish 0.6423 0.0009
The numbers of meiotic spermatocysts were quantitated as the percentage of the total number of spermatocysts in 50 tubules from 10 zebrafish of each
brca2 genotype. The numbers of spermatocysts per 50 tubules were compared between brca2 genotypes by the unpaired t test (GraphPad Software, www.
graphpad.com/quickcalcs/ttest1.cfm). The numbers of meiotic spermatocysts were compared between brca2 genotypes using the unpaired t test with Welch’s
correction (GraphPad Prism version 5.0).
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Table S3. Analysis of age at tumor onset in brca2Q658X homozygous;tp53M214K homozygous zebrafish, brca2Q658X
heterozygous;tp53M214K homozygous zebrafish, and the parent line of tp53M214K homozygous zebrafish
brca2Q658X−/−;tp53M214K−/− brca2Q658X+/−;tp53M214K−/− tp53M214K−/−
































Total 8 9 32
Mean age, mo 8.7 9.2 14.3
brca2Q658X−/−;tp53M214K−/− brca2Q658X+/−;tp53M214K−/−
tp53 M214K−/− P < 0.0001 P < 0.0001
brca2Q658X+/−;tp53M214K−/− P = 0.5643
Data sets were compared using the unpaired t test (GraphPad Prism version 5.0).
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Table S4. Analysis of tumors in zebrafish from an incross of brca2Q658X heterozygous;tp53M214K heterozygous zebrafish
and in a subset of zebrafish from the parent line of tp53M214K homozygous zebrafish
Specimen Age, mo Sex Diagnosis Primary site(s)
brca2Q658X−/−;tp53M214K−/−
1 7.0 M MPNST Coelom
MPNST Eye
2 7.0 F MPNST Ovary
3 7.0 M MPNST Coelom
MPNST Eye
4* 8.0 ND Eye mass with proptosis Eye
5 9.0 M MPNST Coelom
6 9.5 ND MPNST Coelom
MPNST Subpharyngeal
Cutaneous hemangiosarcoma Tail
7 11.0 M Seminoma Testis
8 11.0 F Rhabdomyosarcoma Head
brca2Q658X+/−;tp53M214K−/−
9 6.5 F MPNST Coelom
10 8.0 F MPNST Ovary
11 8.0 F MPNST Ovary
12 8.5 F MPNST Coelom
MPNST Eye
13 8.5 M Sarcoma Coelom
14 10.0 F Sarcoma Ovary
15 11.0 M MPNST Coelom
MPNST Eye
16 11.0 F MPNST Coelom
17 11.0 F Intestinal adenocarcinoma Intestine
Cutaneous hemangioma Body wall
brca2Q658X+/+;tp53M214K−/−
18 10.0 F Primitive neuroectodermal tumor Coelom
19 11.0 F MPNST Body wall
tp53M214K−/− parent line
20 7.0 F MPNST Liver
21 10.0 F MPNST Caudal coelom/ovary
22 11.0 F MPNST Caudal coelom/ovary
23 11.5 M Rhabdomyosarcoma Tail
24 11.5 F MPNST Coelom
25 12.0 M MPNST Eye
Rhabdomyosarcoma Tail
MPNST, malignant peripheral nerve sheath tumor; ND, not determined.
*Specimen 4 was not available for histological analysis.
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